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1. General Experimental Details 
General 
For the synthetic procedures, standard Schlenk techniques under an inert gas atmosphere (Ar 
or N2) were used, unless otherwise stated. Materials obtained from commercial sources were 
used without further purification. All glassware was flame dried and cooled under a stream of 
nitrogen. 
Materials 
Dichloromethane, tetrahydrofuran, diethyl ether and toluene were obtained from a PureSolv 
SPS-400-5 Solvent Purification System. Ethyl acetate was dried over K2CO3, then distilled 
under a nitrogen atmosphere and stored over 3 Å molecular sieves. Dry organic solvents and 
distilled water used for cross-coupling reactions were additionally degassed by bubbling argon 
through the solvent for 30 min. For reactions/work-up procedures in air, p.a. grade solvents 
were used. Petroleum ether refers to alkanes with a boiling point range of 40-60°C. 
(1,3-Bis-(2,4,6-trimethylphenyl)imidazolium chloride,S1 phenylthiazoline,S2 and 1-methyl-2-
phenylimidazoleS3 were synthesised according to literature procedures. 2-Phenylthiazole, 2-
phenylpyrimidine, 2-(4-acetyl)phenylpyridine, and 2-(4-cyano)phenylpyridine were prepared 
by cross-coupling reactions of corresponding phenylboronic acids and heterobromides as 
described in section 2. 2-(4-Acetyl)phenyloxazoline and 2-(4-(pyridin-2-yl)phenyl)-4,5-
dihydrooxazole were obtained from the reaction between corresponding aryl nitriles and amino 
alcohols catalysed by [Cu(Cl)(IPr)].S4 Anhydrous Na[BArF24] (BArF24 = tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate)) was obtained following Bergman’s synthesis,S5 followed 
by recrystallising the crude Na[BArF24]·x(solvent) prior to drying.S6 Phosphine/NHC 
monodentate complex Ir-1 with the BArF24 counterion was synthesised from neutral 
chlorocarbene complex Ir-2S7 in a procedure adapted from that published before for preparation 
of corresponding complexes with BF4 and OTf counterions.
S8 
Flash column chromatography was carried out using silica gel (230-400 mesh). Thin layer 
chromatography (TLC) was performed using Merck silica plates coated with fluorescent 
indicator and visualised by UV light (254 nm) 
Analysis 
NMR Spectroscopy: 1H (400 MHz), 13C{1H} (101 MHz), 11B (128 MHz) 19F (376 MHz) and 
31P{1H} (162 MHz) NMR spectra were obtained on a Bruker AV3-400 instrument with a liquid 
nitrogen Prodigy cryoprobe. The chemical shifts (δ) are reported in ppm relative to the residual 
protonated solvent for 1H NMR or solvent signal for 13C{1H} NMR (CDCl3: δH 7.26 ppm and 
δC 77.16 ppm; DMSO-d6: δH 2.50 ppm and δC 39.51 ppm; C6D6: δH 7.16 ppm; acetone-d6: δH 
2.05 ppm).S9 Coupling constants (J) are reported in Hz and refer to 3JH-H couplings, unless 
otherwise stated. Multiplicities are expressed with s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), br (broad signal). If no multiplicity is given for 13C{1H} data, the signal is a 
singlet. NMR assignments were made using additional 2D NMR experiments where necessary. 
Infrared Spectroscopy: Infrared (IR) spectra were collected on a Shimadzu IRAffinity-1 
Spectrophotometer with only major peaks being reported. 
Elemental analysis was performed using a Perkin-Elmer CH2400 instrument.  
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Figure S1. Scope of the substrates used in the study 
S4 
 
2. Synthesis and Characterisation 
2.1. Synthesis of Iridium (I) Complexes 
Synthesis of 1,3-Bis-(2,4,6-trimethylphenyl)imidazolium chloride (IMes·HCl)S1 
N,N'-dimesitylethanediimine 
 
2,4,6-Trimethylaniline (84.2 mL, 0.60 mol, 2.0 equiv.) was dissolved in methanol (200 mL) 
and cooled to 0 °C, and a solution of 40% glyoxal in water (34.4 mL, 0.30 mol, 1.0 equiv.) 
with one or two drops of formic acid was added. The solution was warmed to room temperature 
and stirred for two days. The yellow suspension was filtrated and washed with a minimum 
volume of methanol and diethyl ether to afford N,N'-dimesitylethanediimine (78.5 g, 0.27 mol, 
90%) as a yellow powder, which was used immediately in the next step. 
1H NMR (400 MHz, CDCl3) δ = 8.11 (s, 2H, CH=N), 6.92 (s, 4H, ArH), 2.30 (s, 6H, p-CH3), 
2.17 (s, 12H, o-CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ = 163.6, 147.6, 134.4, 129.1, 126.7, 20.9, 18.3. 
NMR data are consistent with the literature.S10 
1,3-Bis-(2,4,6-trimethylphenyl)imidazolium chloride (IMes·HCl) S1 
 
Paraformaldehyde (8.05g, 0.27 mol, 1.0 equiv.) was suspended in a solution of 4M 
hydrochloric acid in dioxane (94 mL, 0.38 mol, 1.4 equiv.) and stirred until complete 
dissolution of the white solid. THF (300 mL) was added, followed by the slow addition of N,N'-
dimesitylethanediimine (78.5 g, 0.27 mol, 1.0 equiv.). The resulting solution was stirred at 40 
°C for 2 days. The suspension was cooled to room temperature and the white precipitate was 
collected by filtration, and washed with THF (100 mL) and diethyl ether (100 mL) to afford 
the crude product, which was recrystallized from a DCM/Et2O mixture to afford 1,3-bis-(2,4,6-
trimethylphenyl)imidazolium chloride (36.6 g, 0.11 mol, 40%) as a white powder. 
1H NMR (400 MHz, CDCl3) δ = 10.64 (s, 1H, N-CH=N), 7.61 (d, J = 0.9 Hz, 2H), 7.02 (s, 4H, 
Ar), 2.33 (s, 6H, p-CH3), 2.17 (s, 12H, o-CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ = 141.4, 139.2, 134.2, 130.7, 130.0, 124.8, 21.2, 17.7. 
NMR data are consistent with the literature.S1   
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Synthesis of Chloro(4–cycloocta–1,5–diene)(1,3-dimesitylimidazoline-2-ylidene) 
iridium(I) [Ir(COD)(IMes)Cl]S7 
 
Bis(1,5-cyclooctadiene)diiridium(I) dichloride (500 mg, 0.75 mmol, 1 equiv.) and potassium 
tert-butoxide (167 mg, 1.50mmol, 2 equiv.) were added to a flame-dried Schlenk tube under 
argon and stirred under vacuum for 5 min. THF (12.5 mL) was added and the mixture was 
stirred under argon for 10 min. IMes‧HCl (508 mg, 1.50 mmol, 2 equiv.) was then added and 
the resulting reaction mixture was stirred for 4 h. The solvent was removed in vacuo, and 
column chromatography (50% ethyl acetate in petroleum ether) afforded the title compound 
(730 mg, 1.14 mmol, 76 %) as yellow solid. The isolated catalyst was dried in a vacuum oven 
(40 °C, 1 mbar) for 24 h before use. This process was repeated batch-wise to obtain a of the 
quantity of Ir-2 necessary for all competition studies and synthesis of Ir-1 catalyst. 
m.p. > 190 °C (decomposition) 
1H NMR (400 MHz, CDCl3) δ = 7.04 – 6.96 (m, 4H, Ar-H), 6.95 (s, 2H, NCH=CHN), 4.19 – 
4.12 (m, 2H, COD CH), 3.01 – 2.94 (m, 2H, COD CH), 2.36 (s, 12H, o-CH3Ar), 2.16 (s, 6H, 
p-CH3Ar), 1.78 – 1.59 (m, 4H, COD CH2), 1.39 – 1.20 (m, 4H, COD CH2). 
13C{1H} NMR (101 MHz, CDCl3) δ = 180.9, 138.8, 137.5, 136.2, 134.5, 129.7, 128.3, 123.4, 
82.7, 51.6, 33.6, 29.1, 21.3, 19.8, 18.4. 
NMR data are consistent with the literature.S7  
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Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate [Na(BArF24)]
S5,S6 
 
A 2.0 M solution of i-PrMgCl in THF (100 mL, 0.20 mol, 6.6 equiv.) was added dropwise over 
45 min to a stirred solution of 1-bromo-3,5-bistrifluoromethylbenzene (30 mL, 0.17 mol, 5.8 
equiv.) in THF (150 mL) chilled to -20 °C. After the reaction was allowed to warm from -20 
°C to 0 °C over 1 h, NaBF4 (3.3 g, 0.03 mol, 1.0 equiv.) was quickly added as a solid under a 
stream of N2. The mixture then stirred for 48 h at 23 °C (under N2). All work-up and purification 
procedures were then carried out under air. The contents of the flask were poured into a solution 
of Na2CO3 (44 g) and NaHCO3 (22 g) in water (600 mL). This mixture was stirred vigorously 
for 1 h and then extracted with diethyl ether (4 × 200 mL). The combined organic layers were 
washed with brine and dried over anhydrous Na2SO4. After filtration of the mixture and rotary 
evaporation of the filtrate, the crude Na[BArF24]·xTHF/Et2O was dried at 100 °C/10–2 mbar 
for 10 h to yield a tacky brown/yellow solid. Dissolving the resulting oily crude material in a 
1:1 mixture of dichloromethane and tetrahydrofuran (30 mL) and cooling the mixture at –23 
°C for 48 h yielded an off-white crystalline solid, which was then recrystallised again under 
the same conditions. Anhydrous Na[BArF24]·THF (12.7 g, 0.014 mmol, 48%) was obtained as 
white solid by drying the resulting crystalline solid under vacuum (< 10–2 mbar) for 10 h. 
Anhydrous Na[BArF24] was stored under an atmosphere of argon. 
1H NMR (400 MHz, acetone-d6) δ = 7.79 (br, 8H, ortho-Ar-H), 7.67 (br, 4H, para-Ar-H).  
13C{1H} NMR (101 MHz, DMSO-d6) δ = 161.0 (q, 1JC–B = 49.9 Hz, ipso-C), 134.0 (br, ortho-
C), 128.5 (qq, 3JC–B = 2.8 Hz, 
2JC–F = 32.2 Hz, meta-C), 124.0 (q, 
1JC–F = 272 Hz, CF3), 117.5 
(br, para-C). 
11B NMR (128 MHz, acetone-d6) δ = -6.65. 
19F NMR (376 MHz, acetone-d6) δ = -63.3. 
NMR data are consistent with the literature.S5 
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Synthesis of 4–cycloocta-1,5-diene(1,3-dimesitylimidazoline-2-ylidene)(triphenyl-
phosphine)iridium(I)tetrakis [(3,5-rifluoromethylphenyl)]borate,  
[(COD)Ir(PPh3)(IMes)]BArF24 S8 
 
[Ir(COD)Cl(IMes)], Ir-2, (200 mg, 0.31 mmol, 1.0 equiv.) and NaBArF24 (275 mg, 0.31 mmol, 
1.0 equiv.) were added to a flame-dried Schlenk tube under an argon atmosphere. The solids 
were then dissolved in anhydrous DCM (10 mL) and stirred for 30 min. The triphenylphosphine 
ligand (82 mg, 0.31 mmol, 1.0 equiv.) was then added slowly, initiating an orange to red colour 
change. After a further 30 min stirring, the reaction mixture was filtered through celite and 
concentrated in vacuo, resulting in a red oil. This residue was purified by column 
chromatography (50% DCM in petroleum ether) to afford the title compound as a red 
crystalline solid (365 mg, 0.21 mmol, 68 %). The isolated catalyst was dried in a vacuum oven 
(40 °C, 1 mbar) for 24 h before use. This process was repeated batch wise to obtain the 
quantities of Ir-1 necessary for all competition studies.  
m.p.: >150 °C (decomposition) 
1H NMR (400 MHz, CDCl3) δ = 7.73 – 7.69 (m, 8H, Ar- BArF24), 7.51 (br, 4H, Ar-BArF24), 
7.45 – 7.39 (m, 3H, Ar-H), 7.31 – 7.24 (m, 8H, Ar-H and NCH=CHN), 7.15 – 7.07 (m, 6H, 
Ar-H), 7.02 (s, 2H, Ar-H), 6.66 (s, 2H, Ar-H), 4.39 – 4.32 (m, 2H, COD-CH), 3.38 – 3.31 (m, 
2H, COD-CH), 2.34 (s, 6H, Ar-CH3), 2.08 (s, 6H, Ar-CH3), 1.75 (s, 6H, Ar-CH3), 1.68 – 1.45 
(m, 6H, COD-CH2), 1.31 – 1.24 (m, 2H, COD-CH2). 
13C{1H} NMR (101 MHz, CDCl3) δ = 178.1 (d, 2JC–P = 8.4 Hz), 161.9 (q, 1JC–B = 49.9 Hz),  
 140.2, 135.6, 135.2, 134.9, 134.8, 132.3, 132.2, 131.4, 131.3, 130.9, 130.6, 129.9, 129.5, 
129.2, 128.9, 128.7, 128.6, 126.2, 124.7 (q, 1JC–F = 272 Hz), 117.6, 80.6, 80.5, 78.7, 31.9, 30.3, 
30.2, 21.2, 20.9, 19.0. 
11B NMR (128 MHz, CDCl3) δ = - 6.64. 
19F NMR (376 MHz, CDCl3) δ = - 62.4. 
31P{1H} NMR (162 MHz, CDCl3) δ = 16.4. 
NMR data are consistent with the literature.S8  
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2.2. Synthesis of Substrates 
2-PhenylthiazolineS2 
 
In air, a 10 mL round-bottom flask was charged with benzonitrile (0.50 g, 4.85 mmol), 
cysteamine hydrochloride (0.83 g, 7.28 mmol) and NaOH (40 mg, 0.97 mmol). The reaction 
was stirred at 80 °C for 2 hours under solvent-free conditions. The crude product was dissolved 
in ethyl acetate (2 mL) and water (10 mL) was added. The layers were separated and the 
aqueous layer was then extracted with ethyl acetate (3 × 10 mL). The combined organic layers 
were dried over MgSO4, filtered and dried under vacuum to give the title compound (0.76 g, 
4.66 mmol, 96%). 
1H NMR (400 MHz, CDCl3) δ = 7.88 – 7.80 (m, 2H, Ar-H), 7.48 – 7.37 (m, 3H, Ar-H), 4.46 
(t, J = 8.3 Hz, 2H, CH2), 3.41 (t, J = 8.3 Hz, 2H, CH2). 
13C{1H} NMR (101 MHz, CDCl3) δ = 169.0, 133.2, 131.4, 128.6, 128.5, 65.1, 33.7. 
NMR data are consistent with the literature.S2 
2-Phenylthiazole 
 
Phenylboronic acid (762 mg, 6.25 mmol, 1.25 equiv.), [NiCl2(PPh3)2] (262 mg, 0.40 mmol, 8 
mol%), K3PO4 (1.59 g, 7.50 mmol, 1.5 equiv.) were added to a flame-dried two-necked round-
bottom flask equipped with a stirrer bar and condenser. The system was evacuated for 5 minutes 
and filled with N2, then dry toluene (10 mL) and 2-bromothiazole (820 mg, 5.0 mmol, 1 equiv.) 
were added. The reaction mixture was heated at reflux overnight (16 h) and was then cooled to 
room temperature before water (50 mL) and Et2O (50 mL) were added. The aqueous layer was 
extracted with diethyl ether (3 × 50 mL). The combined organic layers were dried over MgSO4, 
filtered, and the solvent was removed under vacuum. The residue was purified by column 
chromatography (10 % Et2O in hexane) to afford the title compound as a yellow oil (163 mg, 
1.01 mmol, 20 %). 
1H NMR (400 MHz, CDCl3) δ = 8.01 – 7.94 (m, 2H, Ar-H), 7.87 (d, J = 3.3 Hz, 1H, Ar-H), 
7.48 – 7.41 (m, 3H, Ar-H), 7.33 (d, J = 3.3 Hz, 1H, CH). 
13C{1H} NMR (101 MHz, CDCl3) δ = 168.6, 143.7, 133.6, 130.1, 129.1, 126.7, 118.9. 
NMR data are consistent with the literature.S11  
S9 
 
1-Methyl-2-phenylimidazoleS3 
 
Methyl iodide (0.48 mL, 7.6 mmol) was added to the biphasic mixture obtained from 2-
phenylimidazole (1.0 g, 6.9 mmol), tetra-n-butylammonium iodide (0.19 g, 0.51 mmol), 50% 
aqueous NaOH (30 mL) and toluene (30 mL). After stirring for 15 min at room temperature, the 
mixture was diluted with toluene (30 mL) and H2O (30 mL). The organic phase was separated, 
dried (MgSO4), and concentrated under reduced pressure to give pale yellow oil (1.03 g, 6.51 
mmol, 97 %). 
1H NMR (400 MHz, CDCl3) δ = 7.65 – 7.60 (m, 2H, Ar-H), 7.48 – 7.37 (m, 3H, Ar-H), 7.12 
(d, J = 1.2 Hz, 1H, CH), 6.97 (d, J = 1.2 Hz, 1H, CH), 3.19 (s, 3H, CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ = 147.9, 130.5, 128.8, 128.8, 128.7, 128.3, 122.5, 34.6. 
NMR data are consistent with the literature. S12 
 
2-Phenylpyrimidine 
 
A flame dried 50 mL round-bottom flask was charged with [PdCl2(dppf)] (40 mg, 0.05 mmol), 
phenylboronic acid (611 mg, 5.0 mmol), Na2CO3 (1.23 g, 12.0 mmol) and suspended in premixed 
1:1 solution of THF/H2O (60 mL). Subsequently, 2-bromopyrimidine (646 mg, 4.0 mmol) was 
added and the reaction mixture was stirred at 80 °C overnight (16 h), and then cooled to room 
temperature. H2O (30 mL) was added to the reaction mixture. The aqueous layer was extracted 
with diethyl ether (3 × 50 mL). The combined organic layers were dried over MgSO4, filtered, 
and the solvent was removed under vacuum. The residue was purified by column 
chromatography (20 % Et2O in hexane) to afford the title compound as a yellow oil (331 mg, 
2.12 mmol, 53 %). 
1H NMR (400 MHz, CDCl3) δ = 8.81 (d, J = 4.9 Hz, 2H, Ar-H), 8.49 – 8.42 (m, 2H, Ar-H), 
7.52 – 7.47 (m, 3H, Ar-H), 7.18 (t, J = 4.8 Hz, 1H, Ar-H). 
13C{1H} NMR (101 MHz, CDCl3) δ = 164.9, 157.4, 137.7, 130.9, 128.7, 128.3, 119.2. 
NMR data are consistent with the literature.S11 
  
S10 
 
2-(4-Acetyl)phenylpyridine 
 
A flame dried 50mL round-bottom flask was charged with [Pd(PPh3)4] (21 mg, 0.018 mmol), 4-
acetylphenylboronic acid (738 mg, 4.50 mmol), potassium carbonate (1.21 g, 9.0 mmol). The solids 
were suspended in premixed toluene/ethanol (3:2) (30 mL). Subsequently, 2-bromopyridine (0.28 
mL, 3.0 mmol) was added and the reaction mixture was stirred for 24 h at 120 °C before being 
allowed to cool to room temperature. Water (100 mL) was added, the layers were separated, and 
the aqueous layer was extracted with diethyl ether (3 x 50 mL). The combined organic layers 
were dried over MgSO4, filtered, and then the solvent was removed under vacuum yielding the 
crude yellow solid. The crude product was dissolved in DCM (5 mL) and passed through a 
short pad of silica which was then washed with further DCM. The solvent was evaporated, and 
the residue was crystallised from a DCM/pentane mixture to afford the product as a white solid 
(517 mg, 2.62 mmol, 87%). 
1H NMR (400 MHz, CDCl3) δ = 8.77 – 8.71 (m, 1H, Ar-H), 8.13 – 8.09 (m, 2H, Ar-H), 8.09 
– 8.04 (m, 2H, Ar-H), 7.82 – 7.78 (m, 2H, Ar-H), 7.33 – 7.27 (m, 1H, Ar-H), 2.65 (s, 3H, CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ = 198.0, 150.1, 137.1, 129.0, 127.2, 123.1, 121.2, 26.9. 
NMR data are consistent with the literature.S13 
2-(4-Acetyl)phenyloxazolineS5 
 
A flame dried vial was charged with [Cu(IPr)(Cl)] (10 mg, 0.02 mmol), 4-acetylbenzonitrile 
(145 mg,1.0 mmol) and NaOAc (16 mg, 0.2 mmol), and evacuated and backfilled with N2. 
Ethanolamine (0.24 mL, 4.0 mmol) was added and the reaction was stirred at 100 °C for 16 h 
under solvent-free conditions. The reaction mixture was cooled to room temperature, dissolved 
in DCM and passed through a short pad of silica with DCM as the eluent. The solvent was 
removed under vacuum yielding a pale yellow solid (60 mg, 0.32 mmol, 32 %). 
1H NMR (400 MHz, CDCl3) δ = 8.06 – 7.97 (m, 4H, Ar-H), 4.47 (t, J = 9.6, 2H, CH2), 4.10 (t, 
J = 9.6, 2H, CH2), 2.63 (s, 3H, CH3). 
13C{1H} NMR (101 MHz, CDCl3) δ = 197.7, 139.1, 132.0, 128.5, 128.4, 68.0, 55.3, 26.9. 
NMR data are consistent with the literature.S14 
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2-(4-Cyano)phenylpyridine 
 
A flame dried 50 mL round-bottom flask was charged with [PdCl2(dppf)] (31 mg, 0.03 mmol), 4-
cyanophenylboronic acid (856 mg, 5.83 mmol), Na2CO3 (1.30 g, 12.0 mmol). The solids were 
suspended in premixed THF/H2O (1:1) (40 mL). Subsequently, 2-bromopyridine (0.38 mL, 4.0 
mmol) was added, the reaction mixture was stirred at 80 °C for 16 h and then cooled to room 
temperature. H2O (30 mL) was added to the reaction mixture, the layers were separated, and the 
aqueous layer was extracted with EtOAc (2 × 30 mL). The combined organic solution was dried 
over MgSO4. The solvent was removed under reduced pressure, and the residue was purified by 
recrystallisation from a DCM/pentane mixture to afford the title compound as yellow solid (554 mg, 
3.07 mmol, 77%). 
1H NMR (400 MHz, CDCl3) δ = 8.75 – 8.67 (m, 1H), 8.12 – 8.07 (m, 2H), 7.82 – 7.72 (m, 
4H), 7.33 – 7.27 (m, 1H). 
13C{1H} NMR (101 MHz, CDCl3) δ = 155.2, 150.1, 143.5, 137.2, 132.6, 127.5, 123.4, 121.1, 
118.9, 112.5. 
NMR data are consistent with the literature.S15 
 
2-(4-(Pyridin-2-yl)phenyl)-4,5-dihydrooxazole S4 
 
A flame dried vial was charged with [Cu(Cl)(IPr)] (135 mg, 0.27 mmol), 2-(4-
cyano)phenylpyridine (500 mg, 2.77 mmol) and NaOAc (114 mg, 1.39 mmol), and evacuated 
and backfilled with N2. Ethanolamine (0.34 mL, 4.0 mmol) was added and the reaction was 
stirred at 100 °C for 16 h under solvent-free conditions. The reaction mixture was cooled to 
room temperature, dissolved in DCM and transferred to a separating funnel containing brine 
(200 mL). The product was extracted with DCM (2 × 50 mL) and dried over MgSO4, filtered, 
and the solvent was removed under vacuum. The residue was purified by column 
chromatography (70 % EtOAc in hexane) to afford the title compound as pale pink solid (248 
mg, 1.10 mmol, 40 %). 
S12 
 
m.p.: 120-125 °C 
1H NMR (400 MHz, CDCl3) δ = 8.76 – 8.68 (m, 1H), 8.11 – 8.01 (m, 4H, Ar-H), 7.81 – 7.74 
(m, 2H), 7.30 – 7.23 (m, 1H), 4.46 (t, J = 9.5, 2H, CH2), 4.09 (t, J = 9.5, 2H, CH2). 
13C {1H} NMR (101 MHz, CDCl3) δ = 164.5, 156.5, 149.9, 142.0, 136.9, 128.7, 128.2, 126.9, 
122.7, 120.9, 67.7, 55.1. 
Anal. Calculated for C14H12N2O: C, 74.98; H, 5.39; N, 12.49. Found: C, 74.28; H, 5.35; N, 
12.34. 
FTIR (neat): 3286, 3047, 2970, 2931, 2990, 2877, 1642, 1572, 1465, 1256, 1071, 1016, 940, 
862, 785,731, 699, 615 cm-1. 
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3. Intermolecular Competition Experiments 
3.1. General Information 
 
Reaction conditions 
The relative rates of hydrogen-deuterium exchange reactions have been determined by 
competition experiments, where equimolar quantities of each of the two substrates bearing 
different DGs and catalytic amounts of iridium complexes were treated with a limiting amount 
of D2 in DCM at 25°C. As a limiting amount of D2 gas should be used to avoid full conversion 
of the substrates, its volume was controlled by adding the required amount of solvent.  
The volume of 0.10 mmol of the D2 gas can be calculated according to the ideal gas law (eq. 
S-1). 
PV = nRT                                                         (S-1) 
n (max) = 0.10 mmol 
T = 298 K (25 oC) 
R = 0.0821 L⋅atm⋅K−1⋅mol−1 
P = 1 atm 
V (max) = nRT/P = 0.10 × 0.0821 × 298 / 1 = 2.45 mL 
As the volume of J. Young Schlenk flasks (Figure S2) used for the competition experiments is 
approximately 8 mL, the use of 6.0 mL of the solvent will lead to less than 1 equivalent of 
deuterium gas. None of the substrates in the study undergo complete deuteration under these 
conditions, which are quite different for those used in most HIE experiments where complete 
deuteration at one site is desired. 
 
Figure S2. The J. Young Schlenk flasks used for competition experiments. 
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General Procedure (GP1) 
The two substrates of interest (0.10 mmol each) were added to one J. Young Schlenk flask, 
along with the catalyst of choice (0.005 mmol, unless otherwise noted) in air. DCM (6 mL) 
was added in such a way to rinse the inner walls of the flask. The flask was then sealed (with 
the gas inlet left open) under air before being cooled in a dry ice–acetone bath. The flask was 
evacuated and flushed with deuterium three times via a balloon. The gas inlet was then closed 
with fast thread tap, creating a sealed atmosphere of deuterium. After sealing the flask, it was 
placed in the thermostated water bath, and the reaction timer was started. The reaction mixture 
was stirred at 25 °C (1 h for catalyst Ir-1 and 16 h for catalyst Ir-2) before the removal of the 
excess deuterium and the opening of the flask to air. The reaction mixture was quenched with 
few drops of MeCN and transferred to a single necked flask together with washings (DCM) 
before removing the solvent under reduced pressure. For NH-containing substrates 
(benzamide, benzenesulfonamide, acetanilide, phenylimidazol(in)e) the residue was directly 
analysed by 1H NMR. For other substrates, the residue was dissolved in a small portion of 1:1 
mixture of petroleum ether and diethyl ether (or EtOAc) and passed through a short plug of 
silica, eluting with a 1:1 mixture of petroleum ether and diethyl ether (or EtOAc) (3 × 2 mL). 
The solvent was evaporated again under reduced pressure and the residue was analysed by 1H 
NMR.  
NMR spectrometer parameters are as follows: the relaxation delay was set to 20 s and the 
number of scans to four or higher when needed. After careful phasing and baseline correction, 
the integration of the signals was carried out manually. 
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Determination of Competition Rate Constants  
The level of deuterium incorporation in the substrates was determined from the obtained 1H 
NMR spectra (eq. S-2). The integrals were calibrated against a peak corresponding to a position 
which does not undergo labelling. In addition, the calibration signal was chosen to have as little 
overlap as possible with other peaks. 
                              (S-2) 
Based on the ratio between the initial and remaining concentrations of non-deuterated 
substrates R, the competition constants κ were determined (eq. S-3). 
                                                  (S-3) 
Initial concentrations of the substrates are defined by mass balance (eq. S-4). 
                                                                (S-4) 
The relative concentrations [R]0 and [R]t were derived using equation (S-5) from the residual 
integral IR(t) of the peak corresponding to H/D positions, and the integral IR(0) of the peak used 
for calibration, which corresponds to both remaining starting material and deuterated product. 
                                                             (S-5) 
where N is the number of protons contributing to the corresponding peak. 
Each combination was analysed three times, and the competition constants are the average of 
all runs. The tables given below for each competition experiment (Table S1 to Table S41) 
summarize the amounts of the reagents used, integrals from the NMR spectra (Figures S3-
S175) used to calculate the relative concentrations of substrates and the values of the 
competition constants κ. 
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Spectral details for unlabelled substrates used in intermolecular competition studies 
Acetophenone 
 
1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.93 (m, 2H, H-3), 7.60 – 7.53 (m, 
1H, H-1), 7.51 – 7.42 (m, 2H, H-2), 2.61 (s, 3H, H-4). 
Incorporation expected at δ 7.99 – 7.93 ppm (H-3) 
Determined against integral at δ 2.61 ppm (H-4) 
1H NMR (400 MHz, DMSO-d6) δ = 7.98 – 7.94 (m, 2H, H-1), 7.67 – 7.61 
(m, 1H, H-3), 7.55 – 7.50 (m, 2H, H-2), 2.58 (s, 3H, H-4). 
Incorporation expected at δ 7.98 – 7.96 ppm (H-3) 
Determined against integral at δ 2.58 ppm (H-4) 
Benzophenone 
 
1H NMR (400 MHz, CDCl3) δ = 7.84 – 7.78 (m, 4H, H-3), 7.63 – 7.53 (m, 
2H, H-1), 7.52 – 7.45 (m, 4H, H-2). 
Incorporation expected at δ 7.84 – 7.78 ppm (H-3) 
Determined against integral at δ 7.63 – 7.53 ppm (H-1) 
Benzamide 
 
1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.77 (m, 2H, H-3), 7.57 – 7.48 (m, 
1H, H-1), 7.48 – 7.39 (m, 2H, H-2), 6.24 (bs, 2H, H-4) 
Incorporation expected at δ 7.86 – 7.77 ppm (H-3) 
Determined against integral at δ 7.48 – 7.39 ppm (H-2) 
1H NMR (400 MHz, DMSO- d6) δ = 7.96 (bs, 1H, H-4), 7.90 – 7.85 (m, 2H, 
H-3), 7.54 – 7.48 (m, 1H, H-1), 7.48 – 7.41 (m, 2H, H-2), 7.35 (s, 1H, H-4) 
Incorporation expected at δ 7.90 – 7.85 ppm (H-3) 
Determined against integral at δ 7.48 – 7.41 ppm (H-2) 
N,N-Dimethylbenzamide 
 
1H NMR (400 MHz, CDCl3) δ = 7.42 – 7.36 (m, 5H, Ar-H), 3.17 – 2.88 (m, 
6H, 2  CH3). 
Incorporation expected at δ 7.43 – 7.36 ppm 
Determined against integral at δ 3.17 – 2.88 ppm 
Ethylbenzoate 
 
1H NMR (400 MHz, CDCl3) δ = 8.08 – 8.02 (m, 2H, H-3), 7.58 – 7.52 (m, 
1H, H-1), 7.47 – 7.40 (m, 2H, H-2), 4.38 (q, J = 7.1 Hz, 2H, CH2), 1.40 (t, J 
= 7.1 Hz, 3H, CH3). 
Incorporation expected at δ 8.07 – 8.03 ppm (H-3) 
Determined against integral at δ 4.38 ppm (OCH2CH3) 
Nitrobenzene 
 
1H NMR (400 MHz, CDCl3) δ = 8.26 – 8.20 (m, 2H, H-3), 7.73 – 7.66 (m, 
1H, H-1), 7.58 – 7.51 (m, 2H, H-2). 
Incorporation expected at δ 8.26 – 8.20 ppm (H-3) 
Determined against integral at δ 7.73 – 7.66 ppm (H-1) 
1H NMR (400 MHz, DMSO- d6) δ = 8.30 – 8.16 (m, 2H, H-3), 7.90 – 7.79 
(m, 1H, H-1), 7.73 – 7.61 (m, 2H, H-2). 
Incorporation expected at δ 8.30 – 8.16 ppm (H-3) 
Determined against integral at δ 7.73 – 7.61 ppm (H-2) 
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Benzenesulfonamide 
 
1H NMR (400 MHz, DMSO-d6) δ = 7.87 – 7.80 (m, 2H, H-3), 7.64 – 7.54 
(m, 3H, H-1 and H-2), 7.36 (bs, 2H, NH2) 
Incorporation expected at δ 7.87 – 7.80 ppm (H-3) 
Determined against integral at δ 7.64 – 7.54 ppm (H-1+H-2) 
(Methylsulfonyl)benzene 
 
1H NMR (400 MHz, DMSO-d6) δ = 7.95 – 7.92 (m, 2H, H-3), 7.76 –7.72 
(m, 1H, H-1), 7.68 – 7.64 (m, 2H, H-2), 3.21 (s, 3H, H-4). 
Incorporation expected at δ 7.95 – 7.92 ppm (H-3) 
Determined against integral at δ 7.68 – 7.64 ppm (H-2) 
Acetanilide 
 
1H NMR (400 MHz, DMSO-d6) δ = 9.90 (bs, 1H, NH), 7.60 – 7.55 (m, 2H, 
H-3), 7.30 – 7.24 (m, 2H, H-2), 7.04 – 6.99 (m, 1H, H-1), 2.04 (s, 3H, H-4). 
Incorporation expected at δ 7.60 – 7.55 ppm (H-3) 
Determined against integral at δ 2.04 ppm (H-4) 
2-phenylpyridine  
 
1H NMR (400 MHz, CDCl3) δ = 8.73 – 8.67 (m, 1H, H-4), 8.02 – 7.98 (m, 
2H, H-3), 7.78 – 7.70 (m, 2H, H-6 and H-7), 7.51 – 7.45 (m, 2H, H-2), 7.45 
– 7.39 (m, 1H, H-1), 7.25 – 7.21 (m, 1H, H-5). 
Incorporation expected at δ 8.02 – 7.98 ppm (H-3) 
Determined against integral at δ 8.73 – 8.67 ppm (H-4) or at δ 7.78 – 7.70 
(H-6+H-7) depending on the competition partner. 
1H NMR (400 MHz, DMSO- d6) δ = 8.69 – 8.65 (m, 1H, H-4), 8.11 – 8.06 
(m, 2H, H-3), 7.97 – 7.93 (m, 1H, H-7), 7.90 – 7.84 (m, 1H, H-6), 7.52 – 
7.46 (m, 2H, H-2), 7.46 – 7.41 (m, 1H, H-1), 7.38 – 7.32 (m, 1H, H-5). 
Incorporation expected at δ 8.11 – 8.06 ppm (H-3) 
Determined against integral at δ 7.90 – 7.84 ppm (H-6)  
2-Phenylpyrimidine 
 
1H NMR (400 MHz, CDCl3) δ = 8.81 (d, J = 4.9 Hz, 2H, H-4), 8.48 – 8.43 
(m, 2H, H-3), 7.52 – 7.48 (m, 3H, H-1 and H-2), 7.18 (t, J = 4.9 Hz, 1H, H-
5) 
Incorporation expected at δ 8.48 – 8.43 ppm (H-3) 
Determined against integral at δ 7.18 ppm (H-5) 
1-phenylpyrazole 
 
1H NMR (400 MHz, CDCl3) δ = 7.92 (d, J = 2.2 Hz, 1H, H-6), 7.75 – 7.68 
(m, 3H, H-3 and H-4), 7.48 – 7.43 (m, 2H, H-2), 7.32 – 7.26 (m, 1H, H-1), 
6.49 – 6.45 (m, 1H, H-5). 
Incorporation expected at δ 7.75 – 7.68 ppm (H-3) 
Determined against integral at δ 7.92 ppm (H-6) 
2-phenyloxozoline 
 
1H NMR (400 MHz, CDCl3) δ = 7.97 – 7.93 (m, 2H, H-3), 7.50 – 7.44 (m, 
1H, H-1), 7.43 – 7.37 (m, 2H, H-2), 4.43 (t, J = 9.5 Hz, 2H, H-4), 4.06 (t, J 
= 9.5 Hz, 2H, H-5). 
Incorporation expected at δ 7.97 – 7.93 ppm (H-3) 
Determined against integral at δ 4.43 ppm (H-4) 
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2-phenylthiazoline 
 
1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.81 (m, 2H, H-3), 7.48 – 7.37 (m, 
3H, H-1 and H-2), 4.46 (t, J = 8.3 Hz, 2H, H-4), 3.41 (t, J = 8.3 Hz, 2H, H-
5). 
Incorporation expected at δ 7.86 – 7.81 ppm (H-3) 
Determined against integral at δ 4.46 ppm (H-4) 
2-phenylthiazole 
 
1H NMR (400 MHz, CDCl3) δ = 8.00 – 7.94 (m, 2H, H-3), 7.87 (d, J = 3.3 
Hz, 2H, H-4), 7.48 – 7.42 (m, 3H, H-2 and H-1), 7.33 (d, J = 3.3 Hz, 2H, H-
5). 
Incorporation expected at δ 8.00 – 7.94 ppm (H-3) 
Determined against integral at δ 7.87 or 7.33 ppm (H-4 or H-5) 
2-phenylbenzothiazole 
 
1H NMR (300 MHz, CDCl3) δ = 8.14 – 8.06 (m, 3H, H-3 and H-4), 7.91 (d, 
J = 8.0 Hz, 1H, H-7), 7.53 – 7.48 (m, 4H, H-2 and H-5), 7.41-7.37 (m, 1H, 
H-6). 
Incorporation expected at δ 8.14 – 8.06 ppm (H-3) 
Incorporation determined against δ 7.91 ppm (H-7) 
1-methyl-2-phenylimidazole 
 
1H NMR (400 MHz, CDCl3) δ = 7.65 – 7.60 (m, 2H, H-3), 7.47 – 7.34 (m, 
3H, H-1 and H-2), 7.12 (d, J = 1.2 Hz, 1H, H-5), 6.97 (d, J = 1.2 Hz, 1H, H-
4), 3.19 (s, 3H, H-6). 
Incorporation expected at δ 7.65 – 7.60 ppm (H-3) 
Incorporation determined against δ 7.12 ppm (H-5) 
2-phenylimidazole 
 
1H NMR (400 MHz, DMSO-d6) δ = 12.49 (bs, 1H, NH), 7.98 – 7.92 (m, 2H, 
H-3), 7.48 – 7.39 (2H, H-2), 7.36 – 7.29 (m, 1H, H-1), 7.13 (s, 2H, H-4 and 
H-5). 
Incorporation expected at δ 7.98 – 7.92 ppm (H-3) 
Incorporation determined against δ 7.13 ppm (H-4+H-5) 
 
2-phenylimidazole 
 
1H NMR (400 MHz, DMSO-d6) δ = 7.86 – 7.80 (m, 2H, H-3), 7.49 – 7.36 
(m, 3H, H-1 and H-2), 3.60 (s, 4H, H-4 and H-5). 
Incorporation expected at δ 7.86 – 7.80 ppm (H-3) 
Incorporation determined against δ 3.60 ppm (H-4+H-5) 
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3.2. Effects of the Reaction Conditions on Competition Rate Constants 
The competition labelling of 2-phenylpyridine and 1-phenylpyrazole was chosen as a model 
reaction to test the influence of catalyst loading, reaction times and solvent on the competition 
rate constants κ.  
 
Mass of reagents: 1-Phenylpyrazole (14.4 mg, 0.1 mmol ); 2-Phenylpyridine (15.5 mg, 0.1 
mmol); for catalyst Ir-2 (2.1 mg for 2.5 mol %, 4.3 mg, 5 mol. %, 6.4 mg for 7.5 mol %, 8.6 
mg for 10 mol %); for catalyst Ir-1 (8.7 mg, 5 mol %); Volume (solvent) = 6.0 mL 
Deuteration expected at δ (R1) = 7.78 – 7.67 ppm and at δ (R2) = 8.04 – 7.97 ppm  
Determined against integral at δ 6.50 – 6.42 for R1 and at δ 8.72 – 8.68 for R2 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.72 – 8.68 (m, 1H, R2), 8.04 – 7.97 (m, 2H/D R2), 7.92 (d, 
J = 2.4 Hz, 1H, R1), 7.78 – 7.67 (m, 2H, R2, 1H, R1, 2H/D R1), 7.52 – 7.38 (3H, R2 and 2H, 
R1), 7.31 – 7.26 (m, 1H, R1), 7.24 – 7.20 (m, 1H, R2), 6.50 – 6.42 (m, 1H, R1) 
 
Catalyst loading  
Competition experiments between 2-phenylpyridine and 1-phenylpyrazole with different 
loadings of the catalyst Ir-2 (2.5 to 10 mol %) were performed in DCM (6.0 mL) following 
General Procedure GP1 for intermolecular competition experiments (time (t) = 16 h). 
Table S1. Competition labelling of 1-phenylpyrazole and 2-phenylpyridine using different loadings of 
catalyst Ir-2. 
Entry 
catalyst 
loading 
(mol %) 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 2.5 1.40 a 1.00 30 1.32  0.86 23 1.35 
2 5.0 1.29 b 1.00 36 1.22 0.85 28 1.32 
3 7.5 1.48 c 1.00 26 1.43  0.94 24 1.10 
4 10 1.17 d 1.00 42 1.09  0.91 40 1.05 
a IR1(t) = 4.12–1.00−(0.862); b IR1(t) =3.99−1.00−(0.852);  
c IR1(t) = 4.36−1.00−(0.942); d IR1(t) = 3.99−1.00−(0.912) 
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Figure S3. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 1, Table S1) 
 
Figure S4. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 2, Table S1) 
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Figure S5. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 3, Table S1) 
 
Figure S6. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 4, Table S1) 
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Time-dependence 
Competition experiments between 1-phenylpyrazole and 2-phenylpyridine with the catalyst Ir-
2 (5 mol %) were performed in DCM (6.0 mL) over different time periods following the 
General Procedure GP1 for intermolecular competition experiments. 
Table S2. Competition labelling of 1-phenylpyrazole and 2-phenylpyridine using catalyst Ir-2 over 
different time periods. 
Entry 
reaction 
time 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1h 1.92a 1.00 4 1.55 0.80 3 1.29 
2 2h 1.89b 1.00 6 1.75 0.91 4 1.44 
3 16h 1.65c 1.00 18 1.75 1.00 13 1.44 
a IR1(t) = 4.52–1.00−(0.802); b IR1(t) =4.71−1.00−(0.912); c IR1(t) = 4.65−1.00−(1.002); 
 
 
 
Figure S7. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 1, Table S2) 
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Figure S8. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 2, Table S2) 
 
 
Figure S9. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (entry 3, Table S2)  
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Solvent effects 
Competition experiments between 1-phenylpyrazole and 2-phenylpyridine with the catalyst Ir-
1 (5 mol %) were performed in various solvents (6.0 mL) following the General Procedure 
GP1 for intermolecular competition experiments (time (t) = 1 h). 
Table S3. Competition labelling of 1-phenylpyrazole and 2-phenylpyridine using catalyst      Ir-1 in 
different solvents. 
Solvent Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
DCM 1 1.26a 1.00 37 1.74 1.18 26 1.49 
 2 0.90b 1.00 55 1.38 1.07 36 1.78 
 3 0.92c 1.00 54 1.40 1.08 35 1.84 
     Average к = 1.71 
a IR1(t) = 4.62–1.00−(1.182); b IR1(t) =4.04−1.00−(1.072); c IR1(t) = 4.08−1.00−(1.082); 
THF 1 1.15a 1.00 43 1.32 1.01 35 1.30 
 2 1.22b 1.00 39 1.36 1.00 32 1.28 
 3 0.95c 1.00 53 1.13 0.96 41 1.40 
      Average к = 1.33 
a IR1(t) = 4.17–1.00−(1.012); b IR1(t) =4.22−1.00−(1.002); c IR1(t) = 3.87−1.00−(0.962); 
Et2O 1 1.17a 1.00 42 1.39 1.05 34 1.30 
 2 0.73b 1.00 64 0.91 0.97 53 1.33 
 3 0.78c 1.00 61 1.03 0.96 46 1.51 
      Average к = 1.38 
a IR1(t) = 4.27–1.00−(1.052); b IR1(t) = 3.67−1.00−(0.972); c IR1(t) = 3.66−1.00−(0.962); 
Toluene 1 0.98a 1.00 51 1.45 1.09 33 1.75 
 2 0.98b 1.00 51 1.42 1.06 33 1.78 
 3 1.11c 1.00 45 1.39 0.98 29 1.71 
      Average к = 1.75 
a IR1(t) = 4.16–1.00−(1.092); b IR1(t) = 4.10−1.00−(1.062); c IR1(t) = 4.07−1.00−(0.982); 
EtOAc 1 1.38a 1.00 31 1.28 0.98 35 0.87 
 2 0.90b 1.00 55 0.84 1.00 58 0.92 
 3 0.88c 1.00 56 0.82 1.00 59 0.92 
       Average к = 0.90  
a IR1(t) = 4.34–1.00−(0.982); b IR1(t) = 3.90−1.00−(1.002); c IR1(t) = 3.88−1.00−(1.002); 
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Figure S10. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (DCM-entry 1, Table S3) 
 
Figure S11. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (DCM-entry 2, Table S3) 
S26 
 
 
Figure S12. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (DCM-entry 3, Table S3) 
 
Figure S13. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (THF-entry 1, Table S3) 
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Figure S14. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (THF-entry 2, Table S3) 
 
Figure S15. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (THF-entry 3, Table S3) 
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Figure S16. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Et2O-entry 1, Table S3) 
 
Figure S17. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Et2O-entry 2, Table S3) 
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Figure S18. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Et2O-entry 3, Table S3) 
 
Figure S19. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (EtOAc-entry 1, Table S3) 
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Figure S20. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (EtOAc-entry 2, Table S3) 
 
Figure S21. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (EtOAc-entry 3, Table S3) 
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Figure S22. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Toluene-entry 1, Table S3) 
 
Figure S23. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Toluene-entry 2, Table S3) 
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Figure S24. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole and 
2-phenylpyridine (Toluene-entry 3, Table S3) 
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3.3. Competition Experiments with [(COD)Ir(IMes)PPh3]BArF24 (Ir-1) 
Table S4. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and benzophenone 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.0 mg 18.2 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.99 – 7.93 ppm and at δ (R2) = 7.84 – 7.77 ppm  
Determined against integral at δ (R1) = 2.61 ppm and at δ (R2) = 7.63 – 7.53 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.93 (m, 2H/D R1), 7.84 – 7.77 (m, 4H/D R2), 7.63 – 7.53 
(m, 1H R1 and 2H R2), 5.52 – 5.42 (m, 2H R1 and 4H R2), 2.60 (s, 3H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 4H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.39 3.00 31 3.07 2.22a 31 0.99 
2 1.08 3.00 46 2.65 2.44b 46 1.01 
3 1.01 3.00 50 2.18 2.12c 49 1.04 
Average κ = 1.01 
a IR2(0) = 3.22 – (3.00/3); b IR2(0) = 3.44 – (3.00/3); c IR2(0) = 3.12 – (3.00/3); 
 
 
Figure S25. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S26. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzophenone (entry 1, Table S4). 
Figure S27. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzophenone (entry 2, Table S4). 
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Figure S28. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzophenone (entry 3, Table S4).  
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Table S5. Determination of the competition rate constant κ from the labelling experiment between 
benzamide and acetophenone 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.1 mg 12.0 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.86 – 7.77 ppm and at δ (R2) = 7.99 – 7.93ppm  
Determined against integral at δ (R1) = 7.59 – 7.39 ppm and at δ (R2) = 2.60 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.93 (m, 2H/D R2), 7.86 – 7.77 (m, 2H/D R1), 7.59 – 7.39 
(m, 3H, R1 and 3H, R2), 6.19 (br, 2H, R1), 2.60 (s, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 2.09 3.78a 17 1.94 3.00 3 6.14 
2 1.57 3.84b 39 1.85 3.00 8 6.27 
3 1.65 3.93c 37 1.86 3.00 7 6.37 
Average κ = 6.26 
a IR1(0) = 6.78 – 3.00; b IR1(0) = 6.84 – 3.00; c IR1(0) = 6.93 – 3.00; 
 
Figure S29. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture.  
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Figure S30. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 1, Table S5) 
 
Figure S31. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 2, Table S5) 
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Figure S32. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 3, Table S5) 
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Table S6. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and N,N-dimethylbenzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.0 mg 14.9 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.99 – 7.93 ppm and at δ (R2) = 7.42 – 7.36 ppm  
Determined against integral at δ (R1) = 7.57 – 7.54 ppm and at δ (R2) = 3.17 – 2.88 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.93 (m, 2H/D R1), 7.57 – 7.54 (m, 1H, R1), 7.47 – 7.43 
(m, 2H, R1), 7.42 – 7.36 (m, 2H/D R2 and 3H, R2), 3.17 – 2.88 (m, 6H, R2), 2.60 (s, 3H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 6H 
%DR2 κ 
1 1.50 3.00 25 1.62a 5.32 9 3.18 
2 1.54 3.00 23 1.96b 6.29 7 3.74 
3 1.45 3.00 28 2.06c 6.59 6 4.82 
Average κ = 3.91 
a IR2(t) = 4.28 – (5.32)/63; b IR2(t) = 5.10 – (6.29)/63; c IR2(t) = 5.35 – (6.59)/63 
 
Figure S33. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S34. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 1, Table S6). 
 
Figure S35. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 2, Table S6). 
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Figure S36. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 3, Table S6). 
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Table S7. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and nitrobenzene. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.0 mg 12.3 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.99 – 7.93 ppm and at δ (R2) = 8.26 – 8.20 ppm  
Determined against integral at δ (R1) = 2.61 ppm and at δ (R2) = 7.49 – 7.43 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.26 – 8.20 (m, 2H/D R2), 7.99 – 7.93 (m, 2H/D R1), 
7.73 – 7.66 (m, 1H, R2), 7.59 – 7.51 (m, 1H, R1 and 2H, R2), 7.49 – 7.43 (m, 2H, R1), 
2.61 (s, 3H, CH3). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.66 3.22 69 1.43 1.00 29 3.52 
2 0.59 2.58 66 1.43 1.00 29 3.19 
3 0.81 2.81 57 1.57 1.00 22 3.46 
Average κ = 3.39 
 
 
Figure S37. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S38. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
nitrobenzene (entry 1, Table S7). 
 
 
Figure S39. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
nitrobenzene (entry 2, Table S7). 
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Figure S40. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
nitrobenzene (entry 3, Table S7). 
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Table S8. Determination of the competition rate constant κ from the labelling experiment between 
nitrobenzene and ethyl benzoate. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.3 mg 15.0 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.26 – 8.20 ppm and at δ (R2) = 8.08 – 8.02 ppm  
Determined against integral at δ (R1) = 7.70 ppm and at δ (R2) = 4.38 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.26 – 8.20 (m, 2H/D, R1), 8.08 – 8.02 (m, 2H/D, R2), 7.70 
(t, J = 7.4 Hz, 1H, R1), 7.59 – 7.51 (m, 2H, R1 and 1H, R2), 7.43 (t, J = 7.6 Hz, 2H, R2), 
4.38 (q, J = 7.1 Hz, 2H, R2), 1.39 (t, J = 7.1 Hz, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 0.88 1.00 56 1.83 2.12 14 5.58 
2 1.04 1.00 48 1.87 2.06 9 6.76 
3 0.76 1.00 62 1.74 2.01 13 6.71 
Average κ = 6.35 
 
 
Figure S41. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S42. 1H NMR (400 MHz, CDCl3) of the competition experiment between nitrobenzene and 
ethyl benzoate (entry 1, Table S8). 
 
Figure S43. 1H NMR (400 MHz, CDCl3) of the competition experiment between nitrobenzene and 
ethyl benzoate (entry 2, Table S8). 
 
S47 
 
 
Figure S44. 1H NMR (400 MHz, CDCl3) of the competition experiment between nitrobenzene and 
ethyl benzoate (entry 3, Table S8). 
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Table S9. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and ethyl benzoate. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 12.0 mg 15.0 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.99 – 7.93 ppm and at δ (R2) = 8.08 – 8.02 ppm  
Determined against integral at δ (R1) = 2.61 ppm and at δ (R2) = 4.38 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.08 – 8.02 (m, 2H/D, R2), 7.99 – 7.93 (m, 2H/D R1), 7.59 
– 7.52 (m, 1H, R1 and 1H, R2 ), 7.49 – 7.40 (m, 2H, R1 and 2H, R2), 4.38 (q, J = 7.1 Hz, 
2H, R2), 2.61 (s, 3H, R1), 1.39 (t, J = 7.1 Hz, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 0.74 3.00 63 1.93 2.14 10 9.63 
2 0.59 3.00 71 2.37 2.66 11 10.58 
3 0.54 3.00 73 1.89 2.13 11 10.95 
Average κ = 10.38 
 
 
Figure S45. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S46. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
ethyl benzoate (entry 1, Table S9). 
 
Figure S47. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
ethyl benzoate (entry 2, Table S9). 
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Figure S48. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
ethyl benzoate (entry 3, Table S9). 
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Table S10. Determination of the competition rate constant κ from the labelling experiment between 
acetanilide and benzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24]  
Mass 12.1 mg 13.5 mg 4.3 mg (2.5 mol %) 
Deuteration expected at δ (R1) = 7.91 – 7.84 ppm and at δ (R2) = 7.60 – 7.55 ppm  
Determined against integral at δ (R1) = 7.47 – 7.41 ppm and at δ (R2) = 7.30 – 7.24 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 9.90 (br, 1H, R2), 7.96 (br, 1H, R1), 7.91 – 7.84 (m, 2H/D, 
R1), 7.60 – 7.55 (m, 2H/D, R2), 7.54 – 7.41 (m, 1H, R1), 7.47 – 7.41 (m, 2H, R1), 7.35 (br, 1H, 
R1), 7.30 – 7.24 (m, 2H, R2), 7.04 –6.99 (m, 1H, R2), 2.04 (s, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.75 1.93 9 1.86 2.00 7 1.35 
2 1.76 1.98 11 1.86 2.00 7 1.62 
3 1.72 1.96 12 1.85 2.00 8 1.68 
Average κ = 1.55 
 
Figure S49. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction mixture.  
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Figure S50. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
benzamide (entry 1, Table S10). 
 
Figure S51. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
benzamide (entry 2, Table S10). 
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Figure S52. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
benzamide (entry 3, Table S10). 
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Table S11. Determination of the competition rate constant κ from the labelling experiment between 
acetanilide and nitrobenzene. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 13.5 mg 12.3 mg 4.3 mg (2.5 mol %) 
Deuteration expected at δ (R1) =7.60 – 7.55 ppm and at δ (R2) = 8.26 – 8.20 ppm  
Determined against integral at δ (R1) = 7.30 – 7.24 ppm and at δ (R2) = 7.87 – 7.81 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 9.90 (br, 1H, R1), 8.26 – 8.20 (m, 2H/D, R2), 7.87 – 
7.81 (m, 1H, R2), 7.70 – 7.65 (m, 2H, R2), 7.60 – 7.55 (m, 2H/D, R1), 7.30 – 7.24 (m, 
2H, R1), 7.04 –6.99 (m, 1H, R1), 2.04 (s, 3H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N =1H 
%DR2 κ 
1 1.11 2.00 45 1.75 0.91 4 15.01 
2 0.81 2.00 60 1.68 0.89 6 15.63 
3 0.94 2.00 53 1.73 0.91 5 14.89 
Average κ = 15.18 
 
 
Figure S53. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction mixture. 
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Figure S54. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
nitrobenzene (entry 1, Table S11). 
 
Figure S55. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
nitrobenzene (entry 2, Table S11). 
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Figure S56. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between acetanilide and 
nitrobenzene (entry 3, Table S11). 
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Table S12. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylpyrimidine and benzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24]  
Mass 15.6 mg 12.1 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.48 – 8.43 ppm and at δ (R2) = 7.85 – 7.77 ppm  
Determined against integral at δ (R1) = 8.81 ppm and at δ 7.55 – 7.39 ppm for R2 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.81 (d, J = 4.9 Hz, 2H, R1), 8.48 – 8.43 (m, 2H/D, R1), 
7.85 – 7.77 (m, 2H/D, R2), 7.55 – 7.39 (m, 3H, R1 and 3H, R2), 7.18 (t, J = 4.8 Hz, 1H, 
R1), 6.20 (br, 2H, R2) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 0.48 2.00 76 2.05 3.61
 a 15 8.90 
2 1.10 2.00 45 2.01 3.40
 b 11 4.97 
3 0.77 2.00 62 1.96 3.34
 c 12 7.48 
Average κ = 7.12 
a IR2(0) = 6.61 – (2.00/23); b IR2(0) = 6.40 – (2.00/23); c IR2(0) = 6.34 – (2.00/23); 
 
Figure S57. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S58. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and benzamide (entry 1, Table S12). 
Figure S59. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and benzamide (entry 2, Table S12). 
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Figure S60. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and benzamide (entry 3, Table S12). 
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Table S13. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylpyridine and acetophenone. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 15.5 mg 12.0 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.02 – 7.98 ppm and at δ (R2) = 7.98 – 7.94 ppm  
Determined against integral at δ (R1) = 7.78 – 7.70 ppm and at δ (R2) = 2.60 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.74 – 8.66 (m, 1H, R1), 8.02 – 7.98 (m, 2H/D, R1), 7.98 
– 7.94 (m, 2H/D, R2), 7.78 – 7.70 (m, 2H, R1), 7.59 – 7.53 (m, 1H, R2), 7.51 – 7.38 (m, 
2H, R2 and 3H, R1), 2.60 (s, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 1.75 2.26 23 1.97 3.00 2 16.92 
2 1.62 2.26 28 1.96 3.00 2 16.48 
3 1.60 2.25 29 1.96 3.00 2 16.88 
Average κ = 16.76 
 
 
Figure S61. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
S61 
 
 
Figure S62. 1H NMR (400 MHz, CDCl3) of the competition experiment between of 2-phenylpyridine 
and acetophenone (entry 1, Table S13).
 
Figure S63. 1H NMR (400 MHz, CDCl3) of the competition experiment between of 2-phenylpyridine 
and acetophenone (entry 2, Table S13). 
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Figure S64. 1H NMR (400 MHz, CDCl3) of the competition experiment between of 2-phenylpyridine 
and acetophenone (entry 3, Table S13). 
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Table S14. Determination of the competition rate constant κ from the labelling experiment between 2-
phenyloxazoline and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 14.7 mg 15.5 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.97 – 7.93 ppm and at δ (R2) = 8.02 – 7.98 ppm 
Determined against integral at δ (R1) = 4.44 ppm and at δ (R2) = 7.78 – 7.70 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.74 – 8.65 (m, 1H, R2), 8.02 – 7.98 (m, 2H/D R1), 7.97 
– 7.93 (m, 2H/D R2), 7.78 – 7.70 (m, 2 R2), 7.51 – 7.37 (m, 3H, R1 and 3H, R2), 7.25 – 
7.20 (m, 1H, R2), 4.44 (t, J = 9.5 Hz, 2H, R1), 4.07 (t, J = 9.5 Hz, 2H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 0.61 1.36 55 1.40 2.00 30 2.25 
2 0.72 1.36 47 1.59 2.00 21 2.77 
3 0.44 1.59 72 1.41 2.00 30 3.68 
Average κ = 2.90 
 
Figure S65. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S66. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 1, Table S14). 
 
Figure S67. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 2, Table S14). 
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Figure S68. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 3, Table S14). 
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Table S15. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylthiazole and 1-phenylpyrazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 16.1 mg 14.4 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.00 – 7.95 ppm and at δ (R2) = 7.76 – 7.66 ppm  
Determined against integral at δ (R1) = 7.87 ppm and at δ (R2) = 7.92 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.00 – 7.95 (m, 2H/D R1), 7.92 (d, J = 2.4 Hz, 1H, R2), 
7.87 (d, J = 3.3 Hz, 1H, R1), 7.76 – 7.66 (m, 2H/D, R2 and 1H, R2), 7.49 – 7.38 (m, 2H, 
R2 and 3H, R1), 7.33 (d, J = 3.3 Hz, 1H, R1), 7.29 (t, J = 7.4 Hz, 1H, R2), 6.47 – 6.46 
(m, 1H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.74 1.00 63 0.75a 1.00 63 1.01 
2 0.87 1.00 57 0.90b 1.00 55 1.04 
3 1.31 1.00 35 1.38c 1.00 31 1.14 
Average κ = 1.07 
a IR2(t) = 1.75 – 1.00; b IR2(t) = 1.90 – 1.00; c IR2(t) = 2.38 – 1.00; 
 
Figure S69. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture.  
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Figure S70. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
1-phenylpyrazole (entry 1, Table S15). 
  
Figure S71. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
1-phenylpyrazole (entry 2, Table S15). 
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Figure S72. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
1-phenylpyrazole (entry 3, Table S15). 
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Table S16. Determination of the competition rate constant κ from the labelling experiment between 2-
phenyloxazoline and 2-phenylthiazoline. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24]  
Mass 14.7 mg 16.3 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.98 – 7.93 ppm and at δ (R2) = 7.86 – 7.81 ppm  
Determined against integral at δ (R1) = 4.06 ppm and at δ (R2) = 3.41 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.98 – 7.93 (m, 2H/D R1), 7.86 – 7.81 (m, 2H/D, R2), 7.51 – 
7.36 (m, 3H, R1 and 3H, R2), 4.49 – 4.38 (m, 2H, R1 and 2H, R2), 4.06 (t, J = 9.5 Hz, 2H, 
R1), 3.41 (t, J = 8.4 Hz, 2H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.05 2.00 48 1.18 2.24 47 1.01 
2 0.87 2.00 57 0.96 2.19 56 1.01 
3 0.73 2.00 64 0.85 2.32 63 1.00 
Average κ = 1.01 
 
Figure S73. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S74. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylthiazoline (entry 1, Table S16). 
 
Figure S75. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylthiazoline (entry 2, Table S16). 
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Figure S76. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylthiazoline (entry 3, Table S16). 
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Table S17. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylthiazoline and 2-phenylthiazole. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 16.3 mg 16.1 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.89 – 7.21 ppm and at δ (R2) = 8.00 – 7.94 ppm  
Determined against integral at δ (R1) = 4.46 ppm and at δ (R2) = 7.33 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.00 – 7.94 (m, 2H/D R2), 7.89 – 7.21 (m, 2H/D, R1 and 1H, 
R2), 7.49 – 7.37 (m, 3H, R1 and 3H, R2), 7.33 (d, J = 3.3 Hz, 1H, R2), 4.46 (t, J = 8.3 Hz, 2H, 
R1), 3.41 (t, J = 8.3 Hz, 2H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.71a 1.96 64 0.75 1.00 63 1.04 
2 0.68b 1.95 65 0.71 1.00 65 1.02 
3 0.75c 1.93 61 0.80 1.00 60 1.03 
Average κ = 1.03 
a IR1(t) = 1.71 – 1.00; b IR1(t) = 1.68 – 1.00; c IR1(t) = 1.75 – 1.00; 
 
Figure S77. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture.  
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Figure S78. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenylthiazole (entry 1, Table S17). 
 
Figure S79. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenylthiazole (entry 2, Table S17). 
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Figure S80. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenylthiazole (entry 3, Table S17). 
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Table S18. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylthiazole and 2-phenylbenzothiazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 16.1 mg 21.1 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.00 – 7.94 ppm and at δ (R2) = 8.14 – 8.06 ppm  
Determined against integral at δ (R1) = 7.33 ppm and at δ (R2) = 7.93 – 7.85 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.14 – 8.06 (m, 2H/D, R2 and 1H, R2), 8.00 – 7.94 (m, 2H/D 
R1), 7.93 – 7.85 (m, 1H, R1 and 1H, R2), 7.54 – 7.35 (m, 3H, R1 and 4H, R2), 7.33 (d, J = 3.3 
Hz, 1H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.60 1.00 70 1.83a 1.08d 15 7.26 
2 0.80 1.00 60 2.06b 1.16e 11 7.71 
3 0.57 1.00 72 1.86c 1.10f 15 7.48 
Average κ = 7.48 
a IR2(t) = 2.91 – 1.00; b IR2(t) = 3.22 – 1.00; c IR2(t) = 2.96 – 1.00;  
d IR2(0) = 2.08 – 1.00; e IR2(0) = 2.16 – 1.00; f IR2(0) = 2.10 – 1.00; 
 
Figure S81. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S82. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
2-phenylbenzothiazole (entry 1, Table S18) 
Figure S83. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
2-phenylbenzothiazole (entry 2, Table S18). 
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Figure S84. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazole and 
2-phenylbenzothiazole (entry 3, Table S18). 
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Table S19. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylpyridine and 2-phenylbenzothiazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 15.5 mg 21.1 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.02 – 7.98 ppm and at δ (R2) = 8.14 – 8.06 ppm  
Determined against integral at δ (R1) = 8.74 – 8.65 ppm and at δ (R2) = 7.93 – 7.85 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.74 – 8.65 (m, 1H, R1), 8.14 – 8.06 (m, 2H/D, R2 and 1H, 
R2), 8.02 – 7.98 (m, 2H/D R1), 7.93 – 7.85 (m, 1H, R2), 7.77 – 7.71 (m, 2H, R1), 7.53 – 7.35 
(m, 3H, R1 and 4H, R2), 7.25 – 7.20 (m, 1H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.58 1.00 21 1.98a 1.06 7 3.45 
2 1.60 1.00 20 2.12b 1.12 5 4.05 
3 1.53 1.00 24 2.02c 1.09 7 3.51 
Average κ = 3.67 
a IR2(t) = 3.04 – 1.06; b IR2(t) = 3.24 – 1.12; c IR2(t) = 3.11 – 1.09;  
 
Figure S85. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S86. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine and 
2-phenylbenzothiazole (entry 1, Table S19). 
 
Figure S87. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine and 
2-phenylbenzothiazole (entry 2, Table S19). 
  
S80 
 
 
Figure S88. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine and 
2-phenylbenzothiazole (entry 3, Table S19). 
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Table S20. Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenylthiazoline. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 15.8 mg 16.3 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.65 – 7.60 ppm and at δ (R2) = 7.85 – 7.80 ppm  
Determined against integral at δ (R1) = 7.12 ppm and at δ (R2) = 4.45 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.85 – 7.80 (m, 2H/D R2), 7.65 – 7.60 (m, 2H/D, R1), 7.48 – 7.36 
(m, 3H, R1 and 3H, R2), 7.12 (d, J=1.2 Hz, 1H, R1), 6.95 (d, J=1.2 Hz, 1H, R1), 4.45 (t, J = 8.3 Hz, 
2H, R2), 3.73 (s, 3H, R1), 3.40 (t, J = 8.3 Hz, 2H, R2) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 0.62 1.00 69 1.72 2.24 23 4.43 
2 0.60 1.00 70 2.06 2.52 18 5.97 
3 1.02 1.00 49 1.91 2.36 19 3.18 
Average κ = 4.53 
 
Figure S89. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S90. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 1, Table S20). 
 
Figure S91. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 2, Table S20). 
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Figure S92. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 3, Table S20). 
  
S84 
 
Table S21. Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 15.8 mg 15.5 mg 8.7 mg 
Deuteration expected at δ (R1) = 7.65 – 7.60 ppm and at δ (R2) =8.02 – 7.96 ppm  
Determined against integral at δ (R1) = 7.14 ppm and at δ (R2) = 8.73 – 8.66 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.73 – 8.66 (m, 1H, R2), 8.02 – 7.96 (m, 2H/D R2), 7.77 – 7.69 (m, 
2H R2), 7.65 – 7.60 (m, 2H/D, R1), 7.50 – 7.36 (m, 3H, R1 and 3H, R2), 7.24 – 7.18 (m, 1H, R2), 
7.12 (d, J=1.2 Hz, 1H, R1), 6.95 (d, J=1.2 Hz, 1H, R1), 3.73 (s, 3H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.59 1.00 70 2.15 1.20 10 10.95 
2 0.51 1.00 75 1.88 1.10 15 8.69 
3 0.67 1.00 67 2.04 1.13 10 10.68 
Average κ = 10.11 
 
Figure S93. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S94. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 1, Table S21). 
 
Figure S95. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 2, Table S21). 
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Figure S96. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 3, Table S21). 
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Table S22. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylpyridine and 2-phenylpyrimidine. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-1 
[(COD)Ir(IMes)PPh3][BArF24] 
Mass 15.5 mg 15.6 mg 8.7 mg 
Deuteration expected at δ (R1) = 8.02 – 7.97 ppm and at δ (R2) = 8.49 – 8.42 ppm  
Determined against integral at δ (R1) = 7.77 – 7.70 ppm and at δ (R2) = 8.80 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.80 (d, J = 4.8 Hz, 2H, R2), 8.73 – 7.67 (m, 1H, R1), 
8.49 – 8.42 (m, 2H/D, R2), 8.02 – 7.97 (m, 2H/D R1), 7.77 – 7.70 (m, 2H, R1), 7.52 – 
7.39 (m, 3H, R1 and 3H, R2), 7.25 – 7.20 (m, 1H, R1), 7.17 (t, J = 4.8 Hz, 1H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.39 1.94 28 1.54 2.00 23 1.28 
2 1.58 1.88 16 1.71 2.00 15 1.11 
3 1.59 1.85 14 1.76 2.00 12 1.18 
Average κ = 1.19 
 
Figure S97. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S98. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine and 
2-phenylpyrimidine (entry 1, Table S22). 
 
Figure S99. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine and 
2-phenylpyrimidine (entry 2, Table S22). 
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Figure S100. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyridine 
and 2-phenylpyrimidine (entry 3, Table S22). 
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3.4. Competition Experiments with (COD)Ir(IMes)Cl (Ir-2) 
Table S23. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and benzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 12.0 mg 12.1 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.95 ppm and at δ (R2) = 7.82 ppm  
Determined against integral at δ (R1) = 2.60 ppm and at δ (R2) = 7.63 – 7.36 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.95 (d, J = 7.5 Hz, H/D R1), 7.82 (d, J = 7.4 Hz, H/D R2), 7.63 – 
7.36 (m, 3H R1 and 3H R2), 6.25 – 6.13 (bs, 2H, R2), 2.60 (s, 3H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 1.76 3.00 12 1.95 3.20a 9 1.42 
2 1.71 3.00 15 1.76 2.93b 10 1.50 
3 1.41 3.00 30 2.22 4.11c 19 1.66 
Average κ = 1.53 
a IR2(0) = 6.20 – 3.00; b IR2(0) = 5.93 – 3.00; c IR2(0) = 7.11 – 3.00; 
 
Figure S101. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture
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Figure S102. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 1, Table S23). 
  
Figure S103. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 2, Table S23). 
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Figure S104. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
benzamide (entry 3, Table S23). 
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Table S24. Determination of the competition rate constant κ from the labelling experiment between 
benzenesulfonamide and acetophenone. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.7 mg 12.0 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.87 – 7.80 ppm and at δ (R2) = 7.99 – 7.93 ppm  
Determined against integral at(R1) = 7.66 – 7.51 ppm and at δ (R2) = 2.58 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 7.99 – 7.93 (m, 2H/D R2), 7.87 – 7.80 (m, 2H/D R1), 7.67 – 
7.49 (m, 3H R1 and 3H R2), 7.35 (br, 2H, R1), 2.58 (s, 3H, R2) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 2.01 4.26a 29 1.45 3.00 28 1.07 
2 1.50 3.80b 41 1.37 3.00 32 1.39 
3 1.66 5.39c 54 1.09 3.00 46 1.27 
Average κ = 1.24 
a IR1(t) = 7.26 – 3.00; b IR1(t) = 6.80 – 3.00; c IR1(t) = 8.39 – 3.00; 
 
 
Figure S105. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture.  
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Figure S106. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and acetophenone (entry 1, Table S24). 
 
 
Figure S107. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and acetophenone (entry 2, Table S24). 
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Figure S108. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and acetophenone (entry 3, Table S24).  
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Table S25. Determination of the competition rate constant κ from the labelling experiment between 
benzenesulfonamide and benzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.7 mg 12.1 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.86 – 7.81 ppm and at δ (R2) = 7.90 – 7.86 ppm  
Determined against integral at δ (R1) =7.63 – 7.54 ppm and at δ (R2) = 7.48 – 7.41 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 7.96 (bs, 1H, R2), 7.90 – 7.86 (m, 2H/D R2), 7.86 – 7.81 (m, 
2H/D R1), 7.63 – 7.54 (m, 3H, R1), 7.54 – 7.49 (m, 1H, R2), 7.48 – 7.41 (m, 2H, R2), 7.35 (bs, 1H, 
R2 and 2H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.30 3.07 36 1.84 2.00 8 5.44 
2 1.44 3.19 32 1.88 2.00 6 6.30 
3 1.55 2.98 22 1.90 2.00 5 4.84 
Average κ = 5.53 
 
  
Figure S109. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture.  
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Figure S110. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and benzamide (entry 1, Table S25). 
 
Figure S111. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and benzamide (entry 2, Table S25). 
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Figure S112. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and benzamide (entry 3, Table S25). 
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Table S26. Determination of the competition rate constant κ from the labelling experiment between 
acetophenone and N,N-dimethylbenzamide. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 12.0 mg 14.9 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.99 – 7.92 ppm and at δ (R2) = 7.42 – 7.35 ppm  
Determined against integral at δ (R1) = 2.60 ppm and at δ (R2) = 3.18 – 2.88 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.92 (m, 2H/D R1), 7.58 – 7.53 (m, 1H, R1), 7.48 – 7.43 
(m, 2H, R1), 7.42 – 7.35 (m, 2H/D R2 and 3H, R2), 3.18 – 2.88 (m, 6H, R2), 2.60 (s, 3H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 6H 
%DR2 κ 
1 0.83 3.00 59 2.99a 9.79 9 9.87 
2 0.94 3.00 53 1.88b 6.12 8 9.24 
3 1.04 3.00 48 2.12c 6.77 6 10.09 
Average κ = 9.73 
a IR2(t) = 7.88 – (9.79) / 6  3; b IR2(t) = 4.94 – (6.12) / 6  3; c IR2(t) = 5.50 – (6.77) / 6  3 
 
 
Figure S113. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture.  
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Figure S114. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 1, Table S26). 
 
Figure S114. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 2, Table S26). 
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Figure S115. 1H NMR (400 MHz, CDCl3) of the competition experiment between acetophenone and 
N,N-dimethylbenzamide (entry 3, Table S26). 
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Table S27. Determination of the competition rate constant κ from the labelling experiment between 
benzenesulfonamide and methylphenylsulfone. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.7 mg 15.6 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.85 – 7.83 ppm and at δ (R2) =7.95 – 7.93 ppm  
Determined against integral at δ (R1) = 7.60 – 7.55 ppm and at δ (R2) = 7.64 – 7.62 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 7.95 – 7.93 (m, 2H/D R2), 7.85 – 7.83 (m, 2H/D R1), 7.76 – 7.72 
(m, 1H, R2), 7.64 – 7.62 (m, 2H, R2), 7.60 – 7.55 (m, 3H, R1), 7.35 (bs, 2H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 3H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.42 2.94 28 1.98 2.00 1 32.07 
2 0.64 2.68 64 1.95 2.00 3 40.55 
3 1.42 3.30 35 1.98 2.00 1 43.56 
Average κ = 38.73 
 
 
Figure S116. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture. 
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Figure S117. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and methylphenylsulfone (entry 1, Table S27). 
 
Figure S118. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and methylphenylsulfone (entry 2, Table S27). 
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Figure S119. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 
benzenesulfonamide and methylphenylsulfone (entry 3, Table S27). 
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Table S28. Determination of the competition rate constant κ from the labelling experiment between 1-
phenylpyrazole and acetophenone. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.4 mg 12.0 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.73 – 7.69 ppm and at δ (R2) = 7.98 – 7.94 ppm  
Determined against integral at δ (R1) = 6.48 – 6.42 ppm and at δ (R2) = 2.60 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.98 – 7.94 (m, 2H/D R2), 7.92 (d, J = 2.4 Hz, 1H, R1), 7.75 – 7.67 
(m, 2H/D R1 and 1H, R1), 7.60 – 7.53 (m, 1H, R2), 7.49 – 7.42 (m, 2H, R1 and 2H, R2), 7.31 – 7.26 
(m, 1H, R1), 6.48 – 6.45 (m, 1H, R1), 2.60 (s, 3H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 3H 
%DR2 κ 
1 0.99a 1.03 52 1.95 3.00 3 28.94 
2 0.91b 1.43 68 1.92 3.00 4 28.05 
3 0.93c 1.05 56 1.95 3.00 3 32.17 
Average κ = 29.72 
a IR1(t) = 2.02 – 1.03; b IR1(t) = 2.34 – 1.43; c IR1(t) = 1.98 – 1.05; 
 
Figure S120. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S121. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and acetophenone (entry 1, Table S28). 
 
Figure S122. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and acetophenone (entry 2, Table S28). 
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Figure S123. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and acetophenone (entry 3, Table S28).  
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Table S29. Determination of the competition rate constant κ from the labelling experiment between 1-
phenylpyrazole and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.4 mg 15.5 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.78 – 7.67 ppm and at δ (R2) = 8.04 – 7.97 ppm  
Determined against integral at δ (R1) = 6.50 – 6.42 ppm and at δ (R2) = 8.72 – 8.68 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.72 – 8.68 (m, 1H, R2), 8.04 – 7.97 (m, 2H/D R2), 7.92 (d, J = 2.4 
Hz, 1H, R1), 7.78 – 7.67 (m, 2H, R2, 1H, R1, 2H/D R1), 7.52 – 7.38 (3H, R2 and 2H, R1), 7.31 – 
7.26 (m, 1H, R1), 7.24 – 7.20 (m, 1H, R2), 6.50 – 6.42 (m, 1H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.65a 1.00 18 1.75 1.00 13 1.44 
2 1.29b 1.00 36 1.22 0.85 28 1.32 
3 1.23c 1.00 39 1.32 0.94 30 1.37 
Average κ = 1.38 
a IR1(t) =4.65–1.00−(1.002); b IR1(t) =3.99−1.00−(0.852); c IR1(t) = 4.11−1.00−(0.942) 
 
Figure S124. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S125. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylpyridine (entry 1, Table S29). 
 
Figure S126. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylpyridine (entry 2, Table S29). 
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Figure S127. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylpyridine (entry 3, Table S29). 
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Table S30. Determination of the competition rate constant κ from the labelling experiment between 2-
phenyloxazoline and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.7 mg 15.5 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.97 – 7.92 ppm and at δ (R2) = 8.02 – 7.97 ppm  
Determined against integral at δ (R1) = 4.44 ppm and at δ (R2) = 8.73 – 8.66 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.73 – 8.66 (m, 1H, R2), 8.02 – 7.97 (m, 2H/D R2), 7.97 – 7.92 
(m, 2H/D R1), 7.77 – 7.69 (m, 2H R2), 7.52 – 7.37 (m, 3H, R1 and 3H, R2), 7.24 – 7.18 (m, 1H, 
R2), 4.44 (t, J = 9.5 Hz, 2H, R1), 4.07 (t, J = 9.5 Hz, 2H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.76 2.00 12 2.95 1.61 8 1.46 
2 1.52 2.00 24 1.66 1.02 19 1.33 
3 1.28 2.00 36 2.02 1.38 27 1.43 
Average κ = 1.41  
 
Figure S128. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S129. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 1, Table S30). 
 
Figure S130. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 2, Table S30).  
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Figure S131. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenyloxazoline 
and 2-phenylpyridine (entry 3, Table S30). 
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Table S31. Determination of the competition rate constant κ from the labelling experiment between 1-
phenylpyrazole and 2-phenylthiazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.4 mg 16.1 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.78 – 7.67 ppm ppm and at δ (R2) = 8.02 – 7.96 ppm  
Determined against integral at δ (R1) = 6.49 – 6.43 ppm and at δ (R2) = 7.88 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.02 – 7.96 (m, 2H/D, R2), 7.92 (d, J = 2.4 Hz, 1H, R1), 7.88 
(d, J = 3.3 Hz, 1H, R2), 7.76 – 7.66 (m, 2H/D, R1 and 1H, R1), 7.49 – 7.39 (m, 2H, R1 and 3H, 
R2), 7.33 (d, J = 3.3 Hz, 1H, R2), 7.29 (t, J = 7.4 Hz, 1H, R1), 6.49 – 6.43 (m, 1H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.82a 1.00 59 1.25 1.10 43 1.58 
2 1.12b 1.00 44 1.52 1.05 28 1.79 
3 1.19c 1.00 41 1.41 1.00 30 1.49 
Average κ = 1.62 
a IR1(t) = 1.82–1.00; b IR1(t) = 2.12−1.00; c IR1(t) = 2.19−1.00; 
 
Figure S132. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S133. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylthiazole (entry 1, Table S31). 
 
Figure S134. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylthiazole (entry 1, Table S31). 
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Figure S135. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-phenylpyrazole 
and 2-phenylthiazole (entry 1, Table S31). 
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Table S32. Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenylthiazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.8 mg 16.1 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.67 – 7.61 ppm and at δ (R2) =8.02 – 7.96 ppm 
Determined against integral at δ (R1) = 7.12 ppm and at δ (R2) = 7.88 ppm  
Spectral details of the deuterated reaction mixture: 
1H NMR (400 MHz, CDCl3) δ = 8.02 – 7.96 (m, 2H/D, R2), 7.88 (d, J = 3.3 Hz, 1H, R2), 7.67 – 7.61 
(m, 2H/D, R1), 7.50 – 7.38 (m, 3H, R1 and 3H, R2), 7.33 (d, J = 3.3 Hz, 1H, R2), 7.12 (d, J = 1.2 
Hz, 1H, R1), 6.95 (d, J = 1.2 Hz, 1H, R1), 3.74 (s, 3H, R1) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.10 1.00 45 1.91 1.00 5 12.98 
2 0.63 1.00 69 1.90 1.03 8 14.29 
3 0.71 1.00 65 1.95 1.06 8 12.39 
Average κ = 13.22 
 
Figure S136. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S137. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazole (entry 1, Table S32). 
 
Figure S138. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazole (entry 2, Table S32). 
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Figure S139. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazole (entry 3, Table S32). 
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Table S33 Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.8 mg 15.5 mg 3.2 mg 
Note: Volume of DCM was increased to 4 mL to obtain higher conversion of both substrates. 
Deuteration expected at δ (R1) = 7.67 – 7.61 ppm and at δ (R2) =8.02 – 7.96 ppm  
Determined against integral at δ (R1) =7.12 ppm and at δ (R2) = 7.77 – 7.69 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.73 – 8.66 (m, 1H, R2), 8.02 – 7.96 (m, 2H/D R2), 7.77 – 7.69 
(m, 2H R2), 7.67 – 7.61 (m, 2H/D, R1), 7.50 – 7.36 (m, 3H, R1 and 3H, R2), 7.24 – 7.18 (m, 
1H, R2), 7.12 (d, J=1.2 Hz, 1H, R1), 6.95 (d, J=1.2 Hz, 1H, R1), 3.73 (s, 3H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.58 1.00 21 2.09 2.32 10 2.26 
2 1.60 1.00 20 2.02 2.28 11 1.84 
3 1.36 0.87 22 1.76 2.00 12 1.93 
Average κ = 2.01 
 
Figure S140. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
S121 
 
Figure S141. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 1, Table S33). 
 
Figure S142. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 2, Table S33). 
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Figure S143. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylpyridine (entry 3, Table S33). 
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Table S34. Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenyloxazoline. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.8 mg 14.7 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.67 – 7.61 ppm and at δ (R2) = 7.98 – 7.90 ppm  
Determined against integral at δ (R1) = 7.12 ppm and at δ (R2) = 4.44 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.98 – 7.90 (m, 2H/D R2), 7.67 – 7.61 (m, 2H/D, R1), 7.50 – 7.36 
(m, 3H, R1 and 3H, R2), 7.12 (d, J=1.2 Hz, 1H, R1), 6.96 (d, J=1.2 Hz, 1H, R1), 4.43 (t, J = 9.5 
Hz, 2H, R2), 4.06 (t, J = 9.5 Hz, 2H, R2), 3.74 (s, 3H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.03 0.73 29 1.92 2.00 4 8.55 
2 1.31 0.93 30 1.91 2.00 5 7.61 
3 1.76 1.05 16 1.96 2.00 2 8.74 
Average κ = 8.30 
 
Figure S144. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S145. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenyloxazoline (entry 1, Table S34). 
 
Figure S146. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenyloxazoline (entry 2, Table S34). 
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Figure S147. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenyloxazoline (entry 3, Table S34). 
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Table S35. Determination of the competition rate constant κ from the labelling experiment between 1-
methyl-2-phenylimidazole and 2-phenylthiazoline. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.8 mg 16.3 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.65 – 7.60 ppm and at δ (R2) = 7.85 – 7.83 ppm  
Determined against integral at δ (R1) = 7.12 ppm and at δ (R2) = 4.45 ppm  
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.85 – 7.83 (m, 2H/D R2), 7.65 – 7.60 (m, 2H/D, R1), 7.48 – 7.36 
(m, 3H, R1 and 3H, R2), 7.12 (d, J=1.2 Hz, 1H, R1), 6.95 (d, J=1.2 Hz, 1H, R1), 4.45 (t, J = 8.3 
Hz, 2H, R2), 3.73 (s, 3H, R1), 3.40 (t, J = 8.3 Hz, 2H, R2) 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 1H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 0.87 1.00 57 1.72 2.32 26 2.78 
2 0.90 1.00 55 1.51 2.34 35 1.82 
3 0.99 1.00 51 1.66 2.26 27 2.28 
Average κ = 2.29  
Figure S148. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S149. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 1, Table S35). 
 
Figure S150. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 2, Table S35). 
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Figure S151. 1H NMR (400 MHz, CDCl3) of the competition experiment between 1-methyl-2-
phenylimidazole and 2-phenylthiazoline (entry 3, Table S35). 
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Table S36. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylthiazoline and 2-phenyloxazoline. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 16.3 mg 14.7 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.86 – 7.81 ppm and at δ (R2) = 7.98 – 7.93 ppm  
Determined against integral at δ (R1) = 3.41 ppm and at δ (R2) = 4.06 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 7.98 – 7.93 (m, 2H/D R2), 7.86 – 7.81 (m, 2H/D, R1), 7.51 – 7.36 
(m, 3H, R1 and 3H, R2), 4.49 – 4.40 (m, 2H, R1 and 2H, R2), 4.06 (t, J = 9.5 Hz, 2H, R2), 3.41 (t, 
J = 8.4 Hz, 2H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.47 2.45 40 1.50 2.00 25 1.78 
2 1.88 2.76 32 1.62 2.00 19 1.82 
3 1.47 2.49 41 1.50 2.00 25 1.83 
Average κ = 1.81 
 
Figure S152. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S153. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenyloxazoline (entry 1, Table S36). 
Figure S154. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenyloxazoline (entry 2, Table S36). 
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Figure S155. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylthiazoline 
and 2-phenyloxazoline (entry 3, Table S36). 
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Table S37. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylpyrimidine and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 15.6 mg 15.5 mg 3.2 mg 
Deuteration expected at δ (R1) = 8.49 – 8.42 ppm and at δ (R2) = 8.02 – 7.97 ppm  
Determined against integral at δ (R1) = 8.80 ppm and at δ (R2) = 7.77 – 7.70 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.80 (d, J = 4.8 Hz, 2H, R1), 8.73 – 7.67 (m, 1H, R2), 8.49 – 8.42 
(m, 2H/D, R1), 8.02 – 7.97 (m, 2H/D R2), 7.77 – 7.70 (m, 2H, R2), 7.52 – 7.39 (m, 3H, R1 and 3H, 
R2), 7.25 – 7.20 (m, 1H, R2), 7.17 (t, J = 4.8 Hz, 1H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 2H 
%DR2 κ 
1 1.70 2.00 15 1.75 2.01 13 1.17 
2 1.52 2.00 24 1.58 1.96 19 1.27 
3 1.56 2.00 22 1.66 2.00 17 1.33 
Average κ = 1.26 
 
Figure S156. Stacked 1H NMR (400 MHz, CDCl3) of non-deuterated substrates and reaction mixture. 
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Figure S157. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and 2-phenylpyridine (entry 1, Table S37). 
 
Figure S158. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and 2-phenylpyridine (entry 2, Table S37). 
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Figure S159. 1H NMR (400 MHz, CDCl3) of the competition experiment between 2-phenylpyrimidine 
and 2-phenylpyridine (entry 3, Table S37). 
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Table S38. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylimidazole and 1-phenylpyrazole. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.4 mg 14.4 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.98 – 7.90 ppm and at δ (R2) = 7.87 – 7.82 ppm  
Determined against integral at δ (R1) = 7.52 – 7.41 ppm and at δ (R2) = 8.49 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 12.51 (br, 1H, R1), 8.49 (d, J = 2.5 Hz, 1H, R2), 7.98 – 7.90 
(m, 2H/D, R1), 7.87 – 7.82 (m, 2H/D, R2), 7.74 (d, J = 1.5 Hz, 1H, R1), 7.52 – 7.41 (m, 2H, R1 
and 2H, R2), 7.36 – 7.29 (m, 1H, R1 and 1H, R2), 7.14 (br, 2H, R1), 6.55 – 6.52 (m, 1H, R2). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.08 2.23 52 1.87 1.00 6 10.79 
2 1.04 2.11 51 1.87 1.00 6 10.53 
3 1.06 2.15 51 1.88 1.00 6 11.43 
Average κ = 10.91 
a IR1(t) = 4.23–1.002; b IR1(t) = 4.11–1.002; c IR1(t) = 4.15–1.002; 
Figure S160. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture.  
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Figure S161. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyrazole (entry 1, Table S38). 
 
Figure S162. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyrazole (entry 2, Table S38). 
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Figure S163. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyrazole (entry 3, Table S38). 
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Table S39. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylimidazole and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.4 mg 15.5 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.98 – 7.92 ppm and at δ (R2) = 8.11 – 8.06 ppm  
Determined against integral at δ (R1) = 7.53 – 7.40 ppm and at δ (R2) = 7.90 – 7.84 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 12.51 (br, 1H, R1), 8.70 –8.65 (m, 1H, R2), 8.11 – 8.06 (m, H/D, 
R2), 7.98 – 7.92 (m, H/D, R1 and 1H, R2), 7.90 – 7.84 (m, 1H, R2), 7.53 – 7.40 (m, 2H, R1 and 3H, 
R2), 7.37 – 7.30 (m, 1H, R1 and 1H, R2), 7.14 (br, 2H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 2H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.74a 2.06 d 64 1.73 1.00 14 7.06 
2 0.80 b 2.06 e 61 1.78 1.00 11 8.12 
3 0.72 c 1.94 f 64 1.74 1.00 13 7.30 
Average κ = 7.49 
a IR1(t) = 1.74-1.00; b IR1(t) = 1.80-1.00; c IR1(t) = 1.72-1.00; 
d IR1(0) = 5.06-1.003; e IR1(0) = 5.06-1.003; f IR1(0) = 4.99-1.003; 
 
Figure S164. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture. 
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Figure S165. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyridine (entry 1, Table S39). 
 
Figure S166. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyridine (entry 2, Table S39).  
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Figure S167. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazole and 1-phenylpyridine (entry 3, Table S39). 
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Table S40. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylimidazoline and 2-phenylpyridine. 
 Substrate R1 Substrate R2 Catalyst 
 
 
 
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.6 mg 15.5 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.90 – 7.81 ppm and at δ (R2) = 8.11 – 8.06 ppm  
Determined against integral at δ (R1) = 3.61 ppm and at δ (R2) = 7.97 – 7.93 ppm 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 8.70 – 8.64 (m, 1H, R2), 8.11 – 8.06 (m, 2H/D, R2), 7.97 – 7.93 
(m, 1H, R2), 7.90 – 7.81 (m, 2H/D, R1 and 1H, R2), 7.53 – 7.39 (m, 3H, R1 and 3H, R2), 7.36 – 
7.29 (m, 1H, R2), 3.61 (m, 4H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 4H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 0.86 a 3.48 51 1.72 1.00 14 4.67 
2 1.17 b 3.37 31 1.81 1.00 10 3.65 
3 1.14 c 3.41 33 1.84 1.00 8 4.83 
Average κ = 4.38 
a IR1(0) = 1.86-1.00; b IR1(0) = 2.17-1.00; c IR1(0) = 2.14-1.00; 
 
Figure S168. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture. 
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Figure S169. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylpyridine (entry 1, Table S40). 
 
Figure S170. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylpyridine (entry 2, Table S40). 
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Figure S171. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylpyridine (entry 3, Table S40). 
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Table S41. Determination of the competition rate constant κ from the labelling experiment between 2-
phenylimidazoline and 2-phenylimidazole. 
 Substrate R1 Substrate R2 Catalyst 
 
  
Ir-2 
[(COD)Ir(IMes)Cl] 
Mass 14.6 mg 14.4 mg 3.2 mg 
Deuteration expected at δ (R1) = 7.86 – 7.80 ppm and at δ (R2) = 7.98 – 7.90 ppm  
Determined against integral at δ = 3.61 ppm for R1 and at δ = 7.36 – 7.29 ppm for R2 
Spectral details of the deuterated reaction mixture:  
1H NMR (400 MHz, DMSO-d6) δ = 7.98 – 7.90 (m, 2H/D, R2), 7.86 – 7.80 (m, 2H/D, R1), 7.50 – 
7.38 (m, 3H, R1 and 3H, R2), 7.36 – 7.29 (m, 1H, R2),7.13 (br, 2H, R2), 3.61 (s, 4H, R1). 
Entry 
IR1(t) 
N = 2H 
IR1(0) 
N = 4H 
%DR1 
IR2(t) 
N = 2H 
IR2(0) 
N = 1H 
%DR2 κ 
1 1.09 3.41 36 1.39 1.00 31 1.23 
2 1.09 3.47 37 1.26 1.00 37 1.01 
3 1.17 3.58 35 1.33 1.00 34 1.04 
Average κ = 1.09 
 
 
Figure S172. Stacked 1H NMR (400 MHz, DMSO-d6) of non-deuterated substrates and reaction 
mixture. 
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Figure S173. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylimidazole (entry 1, Table S41). 
 
Figure S174. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylimidazole (entry 2, Table S41). 
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Figure S175. 1H NMR (400 MHz, DMSO-d6) of the competition experiment between 2-
phenylimidazoline and 2-phenylimidazole (entry 3, Table S41). 
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3.5. Linear Regression Analysis. 
Table S42. Linear regression analysis for krel determination for catalyst Ir-1. 
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Table S43. Linear regression analysis for krel determination for catalyst Ir-2. 
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Figure S176. Plot of experimental versus calculated (from linear regression) competition constants 
κ for catalyst Ir-1. 
 
 
Figure S177. Plot of experimental versus calculated (from linear regression) competition constants 
κ for catalyst Ir-2.  
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4. Intramolecular Competition Experiments 
4.1. General Information 
 
General Procedure (GP2) 
The substrate (0.10 mmol) and the catalyst (0.005 mmol) of choice were added to one J. Young 
Schlenk flask under air. The solvent, DCM (6 mL), was added in such a way to rinse the inner 
walls of the flask. The flask was then sealed (with gas inlet left open) under air before being 
cooled in a dry ice–acetone bath. The flask was evacuated and flushed with deuterium three 
times via a balloon. The gas inlet was then closed with fast thread tap, creating a sealed 
atmosphere of deuterium. After sealing the flask was placed in the thermostated water bath at 
25 °C and the reaction timer was started. The reaction mixture was stirred for 1 h (for catalyst 
Ir-1) or 16 h (for catalyst Ir-2) before removing excess deuterium and replacing it with air. 
The reaction mixture was quenched with few drops of MeCN and transferred to a single necked 
flask together with washings (DCM) before removing the solvent under reduced pressure. The 
residue was dissolved in a small portion of 1:1 mixture of petroleum ether with diethyl ether 
(or ethyl acetate) and passed through a short plug of silica, eluting with a 1:1 mixture of 
petroleum ether and diethyl ether (3 × 2 mL), or a 1:1 mixture of petroleum ether with ethyl 
acetate where necessary, depending on the substrates used. The solvent was evaporated under 
reduced pressure and the residue was analysed directly by 1H NMR spectroscopy.  
Determination of Competition Rate Constants  
The level of deuterium incorporation (%D) in the substrates was determined by 1H NMR. The 
integrals were calibrated against a peak corresponding to a position not expected to be labelled. 
Equations S-6 and S-7 were used to calculate the extent of labelling and competition rate 
constant κ´: 
                             (S-6) 
                                     (S-7) 
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4.1. Competition Experiments with [(COD)Ir(IMes)PPh3]BArF24 (Ir-1) 
Labelling of p-nitroacetophenone 
 
According to GP2: 16.5 mg of substrate and 8.7 mg of catalyst 
Spectral details of the reaction mixture: 
1H NMR (400 MHz, CDCl3) δ = 8.33 – 8.30 (m, 2H, H/DB), 8.13 – 8.09 (m, 2H, H/DA), 2.68 (s, 3H, 
CH3) 
Deuteration expected at δ (HA) = 8.13 – 8.09 ppm and δ (HB) = 8.33 – 8.30 ppm.  
Determined against integral at δ = 2.68 ppm. 
Table S44. Determination of the competition rate constant κ´ from the labelling of p-nitroacetophenone. 
Entry 
residual integral 
(H/DA) % DA 
residual integral 
(H/DB) % DB κ´ 
1 0.84 58 1.13 44 1.33 
2 1.12 44 1.32 34 1.29 
3 0.97 52 1.22 39 1.32 
Average  51  39 1.32 
 
 
 
Figure S178. 1H NMR (400 MHz, CDCl3) of labelled p-nitroacetophenone (entry 1, Table S44) 
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Figure S179. 1H NMR (400 MHz, CDCl3) of labelled p-nitroacetophenone (entry 2, Table S44) 
 
Figure S180. 1H NMR (400 MHz, CDCl3) of labelled p-nitroacetophenone (entry 3, Table SX)  
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Labelling of ethyl 4-nitrobenzoate 
 
According to GP2:19.5 mg of substrate and 8.7 mg of catalyst 
Spectral details of the reaction mixture: 
1H NMR (400 MHz, CDCl3) δ 8.30 – 8.26 (m, 2H, H/DA), 8.23 – 8.18 (m, 2H, H/DB), 4.43 (q, J = 7.1 
Hz, 2H, CH2), 1.42 (t, J = 7.1 Hz, 3H, CH3). 
Deuteration expected at δ (HA) = 8.30 – 8.26 ppm and δ (HB) = 8.23 – 8.18 ppm.  
Determined against integral at δ = 4.43 ppm. 
 
Table S45. Determination of the competition rate constant κ´ from the labelling of ethyl 4-
nitrobenzoate. 
Entry 
residual integral  
(H/DA) 
% DA 
residual integral  
(H/DB) 
% DB κ´ 
1 0.85 58 1.09 46 1.26 
2 0.81 60 1.11 45 1.34 
3 1.23 39 1.34 33 1.17 
Average  52  41 1.26 
 
Figure S181. 1H NMR (400 MHz, CDCl3) of labelled ethyl 4-nitrobenzoate (entry 1, Table S45) 
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Figure S182. 1H NMR (400 MHz, CDCl3) of labelled ethyl 4-nitrobenzoate (entry 2, Table S45) 
 
Figure S183. 1H NMR (400 MHz, CDCl3) of labelled ethyl 4-nitrobenzoate (entry 3, Table S45)  
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Labelling of 4-acetyl-1-(pyridin-2-yl)benzene 
 
According to GP2: 19.7 mg of substrate and 8.7 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.76 – 8.68 (m, 1H, Ar), 8.12 – 8.08 (m, 2H, HA), 8.07 – 8.03 (m, 2H, 
HB), 7.80 – 7.75 (m, 2H, Ar), 7.31 – 7.26 (m, 1H, Ar), 2.65 (s, 3H, CH3). 
Deuteration expected at δ (HA) = 8.12 – 8.08 ppm and δ (HB) = 8.07 – 8.03 ppm. 
Determined against integral at δ = 2.65 ppm. 
Note: Small signals, corresponding to the Ir-1 catalyst, were present in the 1H NMR spectra, however 
there is no overlap with the substrate signals. 
 
Table S46. Determination of the competition rate constant κ´ from the labelling of 4-acetyl-1-(pyridin-
2-yl)benzene. 
Entry 
residual integral  
(H/DA) 
% DA 
residual integral 
(H/DB) 
% DB κ´ 
1 1.51 25 1.97 1.5 16.33 
2 1.66 17 1.98 1.0 17.00 
3 1.55 23 1.97 1.5 15.00 
Average  21  1.3 16.11 
 
Figure S184. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 1, Table 
S46) 
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Figure S185. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 2, Table 
S46) 
 
Figure S186. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 3, Table 
S46)  
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Labelling of 2-(4-acetyl)phenyloxazoline 
 
According to GP2: 18.9 mg of substrate and 8.7 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.06 – 8.01 (m, 2H, HA), 8.01 – 7.96 (m, 2H, HB), 4.47 (t, J = 9.6 Hz, 
3H, CH2), 4.10 (t, J = 9.6 Hz, 2H, CH2), 2.62 (s, 3H, CH3). 
Deuteration expected at δ (HA) = 8.06 – 8.01 ppm and δ (HB) = 8.01 – 7.96 ppm.  
Determined against integral at δ = 4.47 ppm. 
Note: Small signals, corresponding to the Ir-1 catalyst, were present in the 1H NMR spectra, however 
they do not overlap with the substrate signals. 
 
Table S47. Determination of the competition rate constant κ´ from the labelling of 2-(4-
acetyl)phenyloxazoline. 
Entry 
residual integral 
(H/DA) % DA 
residual integral 
(H/DB) % DB κ´ 
1 0.41 80 1.96 2.0 39.75 
2 0.44 78 1.96 2.0 39.00 
3 0.76 62 1.97 1.5 41.33 
Average    73   1.8 40.03 
 
Figure S187. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 1, Table S47) 
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Figure S188. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 2, Table S47) 
 
Figure S189. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 3, Table S47)  
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Labelling of 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole 
 
According to GP2: 22.4 mg of substrate and 8.7 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, C6D6) δ = 8.56 – 8.51 (m, 1H, Ar-H), 8.36 – 8.32 (m, 1H, HA), 8.17 – 8.11 (m, 
2H, HB), 7.25 – 7.21 (m, 1H, Ar-H), 7.11 – 7.04 (m, 1H, Ar-H), 6.66 – 6.61 (m, 1H, Ar-H), 3.77 – 
3.69 (m, 2H, CH2), 3.67 – 3.58 (m, 2H, CH2). 
Deuteration expected at δ (HA) = 8.36 – 8.32 ppm and δ (HB) = 8.17 – 8.11 ppm.  
Determined against integral at δ = 6.66 – 6.61 ppm. 
Note: Small signals, corresponding to the Ir-1 catalyst, were present in the 1H NMR spectra, however 
they do not overlap with the substrate signals. 
Table S48. Determination of the competition rate constant κ´ from the labelling of 2-(4-(pyridin-2-
yl)phenyl)-4,5-dihydrooxazole. 
Entry 
residual integral 
(H/DA) % DA 
residual integral 
(H/DB) % DB κ´ 
1 0.80 60 1.45 28 2.18 
2 0.42 79 1.57 22 3.67 
3 0.48 76 1.62 19 4.00 
Average    72  23 3.29 
 
Figure S190. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
1, Table S48) 
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Figure S191. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
2, Table S48) 
 
Figure S192. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
3, Table S48) 
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4.2. Competition Experiments with (COD)Ir(IMes)Cl (Ir-2) 
Labelling of 4-acetyl-1-(pyridin-2-yl)benzene 
 
According to GP2: 19.7 mg of substrate and 3.2 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.76 – 8.72 (m, 1H), 8.13 – 8.09 (m, 2H, HA), 8.09 – 8.04 (m, 2H, 
HB), 7.82 – 7.78 (m, 2H, Ar), 7.33 – 7.27 (m, 1H, Ar), 2.65 (s, 3H, CH3). 
Deuteration expected at δ (HA) = 8.13 – 8.09 ppm and δ (HB) = 8.09 – 8.04 ppm.  
Determined against integral at δ = 2.65 ppm. 
Table S49. Determination of the competition rate constant κ´ from the labelling of 4-acetyl-1-
(pyridin-2-yl)benzene. 
Entry residual integral 
(H/DA) 
% DA residual integral 
(H/DB) 
% DB κ´ 
1 1.32 34 1.96 2 17.00 
2 1.52 24 1.97 2 16.00 
3 1.21 40 1.95 3 15.80 
Average 
 
33 
 
2 16.27 
 
 
Figure S193. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 1, Table 
S49). 
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Figure S194. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 2, Table 
S49). 
 
Figure S195. 1H NMR (400 MHz, CDCl3) of labelled 4-acetyl-1-(pyridin-2-yl)benzene (entry 3, Table 
S49). 
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Labelling of 2-(4-acetyl)phenyloxazoline 
 
According to GP2: 18.9 mg of substrate and 3.2 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, CDCl3) δ = 8.06 – 8.01 (m, 2H, HA), 8.01 – 7.96 (m, 2H, HB), 4.47 (t, J = 9.6 Hz, 
3H, CH2), 4.10 (t, J = 9.6 Hz, 2H, CH2), 2.62 (s, 3H, CH3). 
Deuteration expected at δ (HA) = 8.06 – 8.01 ppm and δ (HB) = 8.01 – 7.96 ppm.  
Determined against integral at δ = 4.47 ppm. 
 
Table S50. Determination of the competition rate constant κ´ from the labelling of 2-(4-
acetyl)phenyloxazoline. 
Entry residual integral 
(H/DA) 
% DA residual integral 
(H/DB) 
% DB κ´ 
1 1.41 30 1.93 4 8.43 
2 1.27 37 1.93 4 10.43 
3 0.48 76 1.88 6 12.67 
Average 
 
47 
 
4 10.51 
 
 
Figure S196. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 1, Table S50) 
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Figure S197. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 2, Table S50) 
 
Figure S198. 1H NMR (400 MHz, CDCl3) of labelled 2-(4-acetyl)phenyloxazoline (entry 3, Table S50) 
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Labelling of 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole 
 
According to GP2: 22.4 mg of substrate and 3.2 mg of catalyst 
Spectral details of the reaction mixture:  
1H NMR (400 MHz, C6D6) δ = 8.56 – 8.51 (m, 1H, Ar-H), 8.36 – 8.32 (m, 1H, HA), 8.17 – 8.11 (m, 2H, 
HB), 7.25 – 7.21 (m, 1H, Ar-H), 7.11 – 7.04 (m, 1H, Ar-H), 6.66 – 6.61 (m, 1H, Ar-H), 3.77 – 3.58 (m, 
4H, 2CH2). 
Deuteration expected at δ (HA) = 8.36 – 8.32 ppm and δ (HB) = 8.17 – 8.11 ppm.  
Determined against integral at δ = 6.66 – 6.61 ppm. 
Table S51. Determination of the competition rate constant κ’ from the labelling of 2-(4-(pyridin-2-
yl)phenyl)-4,5-dihydrooxazole. 
Entry residual integral 
(H/DA) 
% DA residual integral 
(H/DB) 
% DB к’ 
1 1.53 24 1.74 13 1.81 
2 1.59 21 1.79 11 1.95 
3 1.53 24 1.79 11 2.24 
Average 
 
23 
 
11 2.00 
 
  
Figure S199. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
1, Table S51) 
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Figure S200. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
2, Table S51) 
Figure S201. 1H NMR (400 MHz, C6D6) of labelled 2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole (entry 
3, Table S51) 
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6. Copies of NMR Spectra 
6.1. 1H and 13C{1H} NMR of synthesised substrates 
N,N'-dimesitylethanediimine 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
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1,3-Bis-(2,4,6-trimethylphenyl)imidazolium chloride (IMes·HCl) 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
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Chloro(4–cycloocta–1,5–diene)(1,3-dimesitylimidazoline-2-ylidene)iridium(I) Ir-2 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
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Soldium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (Na[BArF24]) 
1H NMR (400 MHz, acetone-d6) 
 
13C{1H} NMR (101 MHz, DMSO-d6) 
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19F NMR (376 MHz, acetone-d6) 
 
11B NMR (128 MHz, acetone-d6) 
 
  
S173 
[(COD)Ir(IMes)(PPh3)]BArF24 Ir-1 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
 
  
S174 
19F NMR (376 MHz, CDCl3) 
 
11B NMR (128 MHz, CDCl3) 
 
31P{1H} NMR (162 MHz, CDCl3) 
  
S175 
2-Phenylthiazoline 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
  
S176 
2-Phenylthiazole 
1H NMR (400 MHz, CDCl3) 
 
  
S177 
1-Methyl-2-phenylimidazole 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
 
  
S178 
2-Phenylpyrimidine 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
  
S179 
2-(4-acetyl)phenylpyridine 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
 
  
S180 
2-(4-acetyl)phenyloxazoline  
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
 
  
S181 
2-(4-cyano)phenylpyridine 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
 
  
S182 
2-(4-(pyridin-2-yl)phenyl)-4,5-dihydrooxazole 
1H NMR (400 MHz, CDCl3) 
 
13C{1H} NMR (101 MHz, CDCl3) 
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6.2. 1H NMR of non-deuterated commercial substrates 
Acetophenone 
1H NMR (400 MHz, CDCl3) 
 
Acetophenone  
1H NMR (400 MHz, DMSO-d6) 
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Benzophenone 
1H NMR (400 MHz, CDCl3) 
 
Benzamide 
1H NMR (400 MHz, CDCl3) 
 
  
S185 
Benzamide 
1H NMR (400 MHz, DMSO-d6) 
 
N,N-Dimethylbenzamide 
1H NMR (400 MHz, CDCl3) 
 
  
S186 
Ethyl benzoate 
1H NMR (400 MHz, CDCl3) 
 
Nitrobenzene 
1H NMR (400 MHz, CDCl3) 
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Nitrobenzene 
1H NMR (400 MHz, DMSO-d6 
 
Benzenesulfonamide 
1H NMR (400 MHz, DMSO-d6) 
 
  
S188 
(Methylsulfonyl)benzene 
1H NMR (400 MHz, DMSO-d6) 
 
Acetanilide 
1H NMR (400 MHz, DMSO-d6) 
 
  
S189 
2-Phenylpyridine 
1H NMR (400 MHz, CDCl3) 
 
2-Phenylpyridine 
1H NMR (400 MHz, DMSO-d6) 
 
  
S190 
1-Phenylpyrazole 
1H NMR (400 MHz, CDCl3) 
 
2-Phenyloxozoline 
1H NMR (400 MHz, CDCl3) 
 
  
S191 
2-Phenylbenzothiazole 
1H NMR (400 MHz, CDCl3) 
 
 
2-Phenylimidazole 
1H NMR (400 MHz, DMSO-d6) 
 
S192 
2-Phenylimidazoline 
1H NMR (400 MHz, DMSO-d6 
 
 
 
 
